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ABSTRACT 
SYNTHESIS OF DIAZAXANTHILIDENES AND APPLICATIONS IN  
CELLULAR IMAGING 
 
Mai N. Tran 
David M. Chenoweth 
 
Natural products have been a valuable source of inspiration for organic chemists, 
both as synthetic challenges and as potential candidates for drug development or other 
biological applications. Xylopyridine A, a nucleic acid binding natural product, had an 
intriguing reported structure with a potentially unique mode of intercalation. We have 
designed its synthesis and successfully obtained the reported structure; however, nucleic 
acid binding studies of the molecule itself could not be carried out due to insolubility. 
Despite this, the monomethylated derivative was water soluble and showed remarkable 
selectivity toward G-quadruplex nucleic acid structures. The derivative also possessed 
great potential as a cellular stain for fluorescent cell imaging due to its large Stokes shift, 
high water solubility, low cytotoxicity, high selectivity toward lysosomes, and the 
capability of in-cell photoconversion. Regioisomers of the derivative were synthesized, 
one of which has shown similar properties with higher photostability and selectivity to 
mitochondria. Many other derivatives of the reported structure of xylopyridine A were 
also made and hold great potential for use as fluorescent cellular dyes for both live and 
fixed specimens with good photoproperties, cell permeability, and high resistance to 
photobleaching. 
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1.1 Background 
Light microscopy has become an indispensable tool in biology and medical 
sciences.1-3 Although many cellular processes have been studied using different 
biological assays, genetic engineering, or crystallography, light microscopy remains a 
unique method to monitor and visualize cellular structures and activities in real time. 
Many light microscopy techniques have been developed over the years utilizing both 
transmitted light and fluorescence. Among transmitted light microscopy techniques, 
bright field microscopy is considered the simplest in which the contrast of the images 
only comes from the differences in light absorbance of different cellular components.4-8 
Phase-contrast9, 10 and differentiate interference contrast (DIC) microscopy11, 12 are also 
commonly used with enhanced contrast. Phase-contrast technique converts sample optical 
path length magnitudes to image intensities while DIC technique relies on local path 
length gradients.13 Although transmitted light microscopy allows visualizing cellular 
morphologies and activities to some extent, the ability to selectively illuminate 
components of interest is still reserved for fluorescence microscopy.14-20 Relying on 
fluorescence with fluorophore-specific excitation and emission ranges, fluorescence 
microscopy offers high sensitivity and high contrast between illuminated compartments 
and a virtually black background. Fluorescence microscopy allows visualization of 
specific organelles, detecting and monitoring their structures, morphologies, distributions, 
and localizations of the desired cellular components in their native environment. Multi-
channel fluorescence imaging can be used to simultaneously monitor different structures 
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of interest and their interactions.21-23 Three-dimensional imaging techniques are also 
available to allow observation and reconstruction of specific organelles.24-29  
1.2 Fluorescent probes for cell imaging 
In fluorescence microscopy, despite occasionally available intrinsic 
fluorescence,30, 31 an external fluorescent source or the expression of fluorescent proteins 
in cells is usually required. As more and more imaging techniques (e.g. two-photon 
microscopy,32-35 single-molecule microscopy, or super-resolution microscopy27, 36) 
emerge to meet the growing needs of in-depth cellular studies, demands for new 
fluorescent probes with various photoproperties have also increased. Fluorescent probes 
are molecules that can absorb light at a specific wavelength and emit light at another, 
typically more red-shifted wavelength. They can either be expressed (as in fluorescent 
proteins), microinjected (as in fluorescent proteins and impermeable fluorescent dyes), or 
simply added to the culture media. The most common fluorescent probes used in cell 
imaging generally include fluorescent proteins and small molecule organic fluorophores. 
 
1.2.1 Fluorescent proteins 
Starting from the discovery, isolation, structure determination, and expression of 
green fluorescent protein (GFP),37 fluorescent proteins have rapidly become an 
established and reliable tool to study biological structures and activities. Fluorescent 
proteins can be genetically fused to any protein of interest, allowing highly selective cell, 
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organelle, or protein labeling. Cellular structures, morphologies, localizations, 
interactions and other processes can be monitored.38-43 Many fluorescent proteins (FPs) 
have been discovered or designed to cover a wide range in the visible light spectrum such 
as BFP (blue), CFP (cyan), GFP (green), YFP (yellow), and RFP or mCherry (red). New 
and improved fluorescent proteins possessing enhanced brightness and photostability 
have also been developed and widely used.44, 45 Despite the wide selection and 
remarkable selectivity, fluorescent proteins are usually large (about 25 kDa),39 which 
limits the ability to detect or visualize small structures and might interfere with protein 
folding and activities. Over-expression of the "fluorescent protein-protein of interest" 
fusion might occasionally cause unexpected effects on cellular processes.46  
 
1.2.2 Small molecule organic fluorophores 
Over the years, organic chemists have developed thousands of fluorescent dyes to 
label different organelles, proteins, and nucleic acids with a wide variety of photophysical 
properties. Compared to fluorescent proteins, organic fluorophores are much smaller, 
typically around 1 kDa,39 which allows detection and visualization of small constructs in 
greater detail with minimal steric interference. With an extensive knowledge of organic 
synthesis in hand, fluorophore structures can be modified to afford a wide range of 
excitation and emission wavelengths, enhanced brightness, photostability, and other 
characteristics to satisfy different demands from various microscopy techniques and 
experiments. Nevertheless, many organic fluorophores still have some common 
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drawbacks such as moderate selectivity, low cell permeability, and active efflux or 
diffusion problems.47 
 
1.2.3 Important properties of fluorescent probes for cell imaging 
With a wide selection of fluorophores for cell imaging, a few important properties 
must be considered including, but not limited to, absorption and emission wavelengths, 
Stokes shift, brightness, photostability, water-solubility, cell-permeability, and 
cytotoxicity (for live cell imaging).48  
 
1.2.3.1 Brightness 
Brightness is the product of extinction coefficient and quantum yield (ε x Φ).48 
Extinction coefficient refers to how strongly the dye can absorb light at a certain 
wavelength. Quantum yield indicates the efficiency of the conversion from absorbed 
photons to emitted light. Using fluorescent dyes with high extinction coefficient and 
quantum yield, the intensity of the excitation light needed can be reduced, minimizing 
photobleaching and phototoxicity. A high quantum yield also means a lower chance of 
certain nonradiative pathways that might lead to radical formation and photobleaching.20 
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1.2.3.2 Photostability 
Photostability is one of the most important characteristics of fluorescent dyes. In 
order to monitor cellular activities, prolonged exposure to excitation light is sometimes 
unavoidable.49, 50 A decrease in intensity due to photobleaching can affect data analysis 
and images qualities. Increasing dye concentrations is not always an option due to 
increased background signal.51 Anti-fading reagents can be used to minimize 
photobleaching but they are mostly used with fixed samples and are relatively 
fluorophore-dependent. Some anti-fading reagents require specific media which causes 
significant sample flattening, limiting the use of three-dimensional imaging.51, 52 
 
1.2.3.3 Water solubility 
Most fluorescent dyes with high brightness and more red-shifted spectra have low 
water solubility due to their normally large highly conjugated hydrophobic cores. These 
dyes must first be dissolved in dimethyl sulfoxide (DMSO) before being added to the 
culture media. DMSO concentration must be kept as low as possible and a control 
experiment with DMSO alone is usually required.  
 
1.2.3.4 Cell permeability 
Cell permeability is an important property for live cell imaging fluorescent 
dyes.53, 54 Except for cell membrane stains, all cellular stains designed to highlight 
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intracellular constructs must be able to penetrate the cell membrane and occasionally the 
nuclear membrane (for nucleic acid stains), either by active transport or passive diffusion. 
Depending on cell permeability, the incubation time of fluorescent dyes can vary from a 
few minutes to hours. Impermeable dyes must be introduced by microinjection. An 
alternative is cell permeabilization using organic solvent (e.g. methanol, acetone) or 
detergents (e.g. TritonX-100, Tween-20), which is only applicable for fixed specimens. 
Occasionally, an efflux inhibitor such as verapamil is needed to prevent active efflux 
pump.55 
 
1.2.3.5 Cytotoxicity 
Fluorescent dyes with low or no cytotoxicity is usually required for live cell 
imaging. Phototoxicity, caused by repeated exposure of the dyes under excitation laser 
over a long period of time, should also be taken into consideration. Limiting dye 
concentration and light intensity to the minimum necessary can help reducing toxicity.56, 
57 
1.3 Photoactivatable fluorescent probes 
Activatable fluorescent dyes are dyes whose photoproperties can vary in response 
to changes in environment or to external stimuli.58 Changes in photoproperties could be 
an increase or decrease in fluorescence intensity or a red- or blue-shift in excitation or 
emission wavelength. These changes can be triggered by light, enzymes, variation in 
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pH,19, 59 environment polarity,60 concentration of metal ions, reactive oxygen, or other 
intracellular analytes. Activatable fluorescent dyes can find applications in fluorescent 
sensors for investigating biological activities, disease study and diagnosis. 
Photoactivatable fluorescent dyes, a group of activatable fluorescent dyes that can be 
triggered by light, are usually used to detect, track, and visualize specific cellular 
components with great spatial and temporal control.36, 61, 62 Photoactivatable fluorescent 
dyes typically give higher signal to noise ratio compared to "always-on" dyes because of 
the virtually black background, even in the presence of excess (but not activated) dye. 
Precise photoactivation with a target spot laser allows illumination of small subsets of 
organelles or proteins, making it possible to monitor trafficking, communication, and 
other dynamic cellular activities without continuous irradiation, significantly reduce 
photobleaching and phototoxicity. Many of the recently developed high-resolution 
microscopy techniques such as STORM,63 PALM,64 FPALM65 also required the use of 
photoactivatable fluorescent dyes. Photoactivatable fluorescent dyes can be broadly 
grouped into three categories: photoactivatable turn-on fluorescent dyes, 
photoconvertible fluorescent dyes, and photoswitchable fluorescent dyes.36 
 
1.3.1 Photoactivatable turn-on fluorescent probes 
Photoactivatable turn-on fluorescent probes are probes the photoproperties of 
which change irreversibly from a non- or weakly fluorescent state to a fluorescent state 
by light of a specific wavelength. These probes are either fluorescent proteins or small 
molecule fluorescent dyes. The first useful example of photoactivatable turn-on 
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fluorescent proteins is photoactivatable green fluorescent protein (PA-GFP), GFP with a 
single T203H mutation.66 After photoactivation with a 413 nm laser, a 100 fold increase 
in fluorescence intensity under a 488 excitation light was observed. The large change in 
fluorescence intensity resulted from a shift of absorption maximum from 400 nm to 504 
nm. Both the pre- and post-activated form emitted at the same range with emission 
maximum at 515-517 nm. Photoactivatable turn-on small molecule fluorescent dyes have 
also been developed utilizing many different activation mechanisms such as 
photouncaging, azide decomposition, or photo-click reaction. Compound 1, a 2,6-
dinitrobenzyl-caged BODIPY dye can be activated by 350 nm light. The uncaged product 
presented more than 600 fold increase in quantum yield. The carboxylic group on the 
benzene ring also served as a handle for conjugation with a SNAP tag ligand, selectively 
labeling the protein of interest (Figure 1.1a).67 Decomposition of the azide group of 
compound 3 using 407 nm laser light yielded aniline 4 with more than 100 fold increase 
in fluorescence intensity. The resultant push-pull system also provided a large 
bathochromic shift, allowing excitation at 549 nm and emission around 613 nm (Figure 
1.1b).68 An intramolecular photo-click reaction between the tetrazole and the olefin 
moieties of compound 5 gave rise to pyrazoline 6 with a 100 fold increase in fluorescence 
(Figure 1.1c). To achieve selective labeling, the photoactivation portion was conjugated 
to a target-directed ligand. A 7-β-alanyltaxol core was used to target microtubules and 
live cell imaging using the resultant photoactivatable fluorophores was conducted.69 
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Figure 1.1. Photoactivatable organic fluorophores. (a) Photoactivation by uncaging mechanism. 
(b) Photoactivation by azide decomposition. (c) Photoactivation by photo-click reaction. 
 
1.3.2 Photoconvertible fluorescent probes 
Photoconvertible dyes are fluorescent dyes that can turn from one fluorescent 
state to another with a different emission wavelength. Photoconvertible dyes offer a 
possibility to observe the pre-activated state, allowing more accurate and precise 
activation. One of the most widely used photoconvertible fluorophores is kaede protein, a 
fluorescent protein discovered and successfully cloned from the stony coral 
Trachyphyllia geoffroyi in 2002.70 Under UV light (350-400 nm), kaede protein can be 
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irreversibly converted from a green to a red fluorescent protein, owing to a beta-
elimination at histidine 62 (Figure 1.2). Very few examples of small molecule 
photoconvertible fluorescent dyes have been reported. A combined Cy5-Cy3 probe71 has 
been introduced as a photoconvertible protein label and a commercially available near-
infrared membrane stain DiR72 has been shown to undergo photoconversion. 
	  
Figure 1.2. Photoconversion of kaede from green to red fluorescent protein via beta-elimination 
of histidine 62. 
	  
1.3.3 Photoswitchable fluorescent probes 
Photoswitchable fluorescent dyes are dyes the fluorescence of which can be 
turned on or off multiple times using different wavelengths. Additional conditions are 
sometimes required such as electron donors, electron acceptors, or nucleophiles. The 
most established fluorescent proteins in this class is dronpa. Employing E-Z 
isomerization of the hydrobenzylidene core, the dronpa fluorophore can be reversibly 
switched on (Z form) under a 405 nm laser or off (E form) by a 488 nm light (Figure 
1.3a). Photoswitchable small molecule fluorophores are also available, such as Cy5 and 
rhodamine dyes. Cy5 can be switched off by a 647 nm light irradiation in the presence of 
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a thiol or phosphine. The non-fluorescent adduct can be eliminated under UV light to 
reverse to the fully conjugated fluorescent state (Figure 1.3b). Rhodamine dyes, on the 
other hand, exploit the non-fluorescent reduced stable radical forms which can be 
achieved by irradiating with 496 nm light (or a wavelength with high absorbance) in the 
absence of oxygen. Suitable electron donors such as thiols are usually added. The 
fluorescent state can be obtained again using a UV light (Figure 1.3c).73 
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Figure 1.3. Photoswitchable fluorescent probes. (a) Dronpa photoswitching mechanism relies on 
E-Z isomerization of the hydrobenzylidene moiety. (b) Cy5 fluorescence can be turned off by the 
formation of a thiol or phosphine adduct under a 647 nm light. The fluorescent state can be 
restored with a UV light. (c) Rhodamine photoswitching was obtained by the generation of a 
long-live reduced non-fluorescent radical, which can be reverted back using a UV light. 
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1.4 Bistricyclic aromatic enes (BAEs) 
Bistricyclic aromatic enes (BAEs) are structures consisting of two fused tricyclic 
moieties connected to each other in the middle via a double bond. BAEs can be divided 
into two categories, homomerous and heteromerous BAEs.74  
	  
Figure 1.4. General structure of bistricyclic aromatic enes (BAEs). 
 
Studies on BAEs have started in the late nineteenth century with the synthesis of 
bifluorenilidene 7, dixanthilidene 8, and bianthrone 9. With the discovery of bianthrone's 
chromism effects triggered by light (photochromism), heat (thermochromism), and 
pressure (piezochromism), BAEs have become appealing models for molecular switch 
and molecular motors. Bianthrone structure is also closely related to a natural product 
hypericin 10 isolated from the plant Hypericum which is believed to work as an antiviral, 
antibiotic, and anti-depression agent.75, 76 Lucigenin 11, a BAE derivative, is a well-
established chemoluminescent probe for superoxide in biology.77 
 
	  15	  
	  
	  
Figure 1.5. Some examples of BAEs.  
 
Many BAEs have been synthesized to investigate their stereochemistry and 
chromic properties. Homomerous BAEs are usually obtained by homo-coupling of the 
correspondent thioketone. Compound 12, one of the homomerous BAEs, was synthesized 
by Levy and coworkers in 2000 using copper powder in refluxing toluene (Scheme 1.1).78 
Heteromerous BAEs are typically synthesized in two steps, as in the synthesis of 13 by 
Biedermann and coworkers in 2006. Hetero-coupling between the diazo derivative of one 
tricyclic moiety and the thioketone of the other was carried out to form a thiirane, which 
was subsequently reduced by triphenylphosphine to obtain the desired BAE 13 (Scheme 
1.2).79 
	  
Scheme 1.1. Synthesis of homomerous BAE 12.  
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Scheme 1.2. Synthesis of heteromerous BAE 13.  
 
1.5 Overview of dissertation 
In chapter 2, inspired by the reported structure of the natural product xylopyridine 
A (E)-3,3'-diazaxanthilidene 14, a nucleic acid binder isolated from the mangrove fungus 
Xylaria in 2009,80 we have devised a synthesis route and obtained the desired product in 
five steps with 41% overall yield. However, significant discrepancies between the 
analytical data of the synthetic compound and the natural isolate indicate probable 
misassignment in the natural product report. Nucleic acid binding studies proved difficult 
due to low solubility in both water and dimethyl sulfoxide. However, methylation has 
been confirmed to be a simple and effective solution. The mono-methylated derivatives 
(E)-15/(Z)-15 were water soluble and exhibited remarkable selectivity for G-quadruplex 
nucleic acid structures.81  
In chapter 3, mono- and di-methylated derivatives of 3,3'-diazaxanthilidene, (E)-
15/(Z)-15 and (E)-16/(Z)-16, were studied for applications in cell imaging. These dyes 
were shown to localize in lysosomes and exhibited many desirable properties for cell 
imaging fluorescent dyes including high water-solubilities, cell permeabilites, large 
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Stokes shifts, and low cytotoxicities. The mono-methylated derivatives (E)-15/(Z)-15 
were also capable of in-cell photoconversion with high spatial and temporal control.82 
In chapter 4, photocyclization/oxidation reaction of 3,3'-diazaxanthlidene was 
discussed. Photoproducts 17 and 18 had higher solubility in dimethyl sulfoxide, 
facilitating cell imaging. Both photoproducts had high quantum yields, high 
photostabilities, high cell-permeabilities, and low cytotoxicities. The methylated 
photoproducts were also introduced with nuclear specificity, especially in fixed 
specimens. 
In chapter 5, compounds (E)-19/(Z)-19, regioisomers of the previous mono-
methylated derivatives (E)-15/(Z)-15, were found to be mitochondria-specific 
photoconvertible fluorescent dyes. Similar properties including water solubility, cell 
permeability, low cytotoxicity, and large Stokes shift were observed. Compared to (E)-
15/(Z)-15, (E)-19/(Z)-19 were significantly more photostable, allowing high 
spatiotemporal control with a lower risk of premature activation.83 
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Figure 1.6. Chemical structure reported for xylopyridine A, its derivatives and isomers.   
	    
	  19	  
	  
1.6 Bibliography 
1.  Bakota, L.; Brandt, R. Int. Rev. Cell Mol. Biol. 2009, 49-103. 
2.  Stephens, D. J.; Allan, V. J. Science  2003, 5616, 82-86. 
3.  Weissleder, R.; Pittet, M. J. Nature 2008, 7187, 580-589. 
4.  Buggenthin, F.; Marr, C.; Schwarzfischer, M.; Hoppe, P. S.; Hilsenbeck, O.; 
Schroeder, T.; Theis, F. J. BMC Bioinformatics 2013, 297. 
5.  Candia, C. N. H.; Gutierrez-Medina, B. PLoS One 2014, 2, e89106. 
6.  Selinummi, J.; Ruusuvuori, P.; Podolsky, I.; Ozinsky, A.; Gold, E.; Yli-Harja, O.; 
Aderem, A.; Shmulevich, I. PLoS One 2009, 10, e7497. 
7.  Zaritsky, A.; Natan, S.; Horev, J.; Hecht, I.; Wolf, L.; Ben-Jacob, E.; Tsarfaty, I. 
PLoS One 2011, 11, e27593. 
8.  Zieba, A.; Waehlby, C.; Hjelm, F.; Jordan, L.; Berg, J.; Landegren, U.; Pardali, K. 
Clin. Chem. 2010, 1, 99-110. 
9.  Kang, M.; Song, S.; Lee, H.; Kim, M. Proc. SPIE 2012, Biomedical Applications in 
Molecular, Structural, and Functional Imaging, 83171X. 
10.  Li, K.; Miller, E. D.; Chen, M.; Kanade, T.; Weiss, L. E.; Campbell, P. G. Med. 
Image Anal. 2008, 5, 546-566. 
11.  Foskett, J. K. Am. J. Physiol. 1988, 255, C566-C571. 
12.  Sun, W.; Wang, G.; Fang, N.; Yeung, E. S. Anal. Chem. 2009, 22, 9203-9208. 
13.  Murphy, D. B.; Davidson, M. W.; Wiley InterScience; Clarence J. Marshall 
Memorial Library Fund 2013, 538. 
14.  Guo, Z.; Park, S.; Yoon, J.; Shin, I. Chem. Soc. Rev. 2014, 1, 16-29. 
15.  Gwozdzinska, P.; Pawlowska, R.; Milczarek, J.; Garner, L. E.; Thomas, A. W.; 
Bazan, G. C.; Chworos, A. Chem. Commun. 2014, 94, 14859-14861. 
16. Johnson, L. V.; Walsh, M. L.; Bockus, B. J.; Chen, L. B. J. Cell Biol. 1981, 3, 526-
535. 
	  20	  
	  
17.  Lavis, L. D.; Raines, R. T. ACS Chem. Biol. 2008, 3, 142-155. 
18.  Schaeferling, M. Angew. Chem. , Int. Ed. 2012, 15, 3532-3554. 
19.  Urano, Y.; Asanuma, D.; Hama, Y.; Koyama, Y.; Barrett, T.; Kamiya, M.; Nagano, 
T.; Watanabe, T.; Hasegawa, A.; Choyke, P. L.; Kobayashi, H. Nat. Med. 2009, 1, 
104-109. 
20.  Lichtman, J. W.; Conchello, J. Nat. Methods 2005, 12, 910-919. 
21.  Falati, S.; Gross, P.; Merrill-Skoloff, G.; Furie, B. C.; Furie, B. Nat. Med. 2002, 10, 
1175-1181. 
22.  Bates, M.; Dempsey, G. T.; Chen, K. H.; Zhuang, X. ChemPhysChem 2012, 1, 99-
107. 
23.  Wan, Y.; Otsuna, H.; Chien, C.; Hansen, C. IEEE Trans. Vis. Comput. Graph. 
2009, 6, 1489-1496. 
24. Carrington, W. A.; Lynch, R. M.; Moore, E. D. W.; Isenberg, G.; Fogarty, K. E.; 
Fay, F. S. Science  1995, 5216, 1483-1487. 
25.  Dommerholt, J.; Schmidt, S.; Temming, R.; Hendriks, L. J. A.; Rutjes, F. P. J. T.; 
van Hest, J. C. M.; Lefeber, D. J.; Friedl, P.; van Delft, F. L. Angew. Chem. , Int. 
Ed. 2010, 49, 9422-9425, S9422. 
26.  Durr, N. J.; Larson, T.; Smith, D. K.; Korgel, B. A.; Sokolov, K.; Ben-Yakar, A. 
Nano Lett. 2007, 4, 941-945. 
27.  Huang, B.; Bates, M.; Zhuang, X. Annu. Rev. Biochem. 2009, 993-1016. 
28.  Jones, S. A.; Shim, S.; He, J.; Zhuang, X. Nat. Methods 2011, 6, 499-505. 
29. Juette, M. F.; Gould, T. J.; Lessard, M. D.; Mlodzianoski, M. J.; Nagpure, B. S.; 
Bennett, B. T.; Hess, S. T.; Bewersdorf, J. Nat. Methods 2008, 6, 527-529. 
30.  Ehlert, B.; Hincha, D. K. Plant Methods 2008, 4, 12. 
31.  Piston, D. W.; Knobel, S. M. Trends Endocrinol. Metab. 1999, 10, 413-417. 
32.  Konig, K. J. Near Infrared Spectrosc. 1997, 1, 27-34. 
33.  Periasamy, A. Proc. SPIE-Int. Soc. Opt. Eng. 1999, Optical Diagnostics of Living 
Cells II, 74-82. 
	  21	  
	  
34.  Piston, D. W. Trends Cell Biol. 1999, 2, 66-69. 
35.  Piston, D. W.; Bennett, B. D.; Ying, G. J. Microsc. Soc. Am. 1995, 1, 25-34. 
36.  Patterson, G.; Davidson, M.; Manley, S.; Lippincott-Schwartz, J. Annu. Rev. Phys. 
Chem. 2010, 345-368. 
37.  Shimomura, O. J. Microsc. 2005, 1, 3-15. 
38.  Davidson, M. W.; Campbell, R. E. Nat. Methods 2009, 10, 713-717. 
39.  Kremers, G.; Gilbert, S. G.; Cranfill, P. J.; Davidson, M. W.; Piston, D. W. J. Cell 
Sci. 2011, 2, 157-160. 
40.  Lippincott-Schwartz, J.; Patterson, G. H. Science  2003, 5616, 87-91. 
41.  Shaner, N. C.; Steinbach, P. A.; Tsien, R. Y. Nat. Methods 2005, 12, 905-909. 
42.  Shaner, N. C.; Patterson, G. H.; Davidson, M. W. J. Cell Sci. 2007, 24, 4247-4260. 
43.  Snapp, E. Curr. Protoc. Cell Biol. 2005, Unit 21.4. 
44.  Cinelli, R. A. G.; Ferrari, A.; Pellegrini, V.; Tyagi, M.; Giacca, M.; Beltram, F. 
Photochem. Photobiol. 2000, 6, 771-776. 
45.  Hendricks, C. A.; Almeida, K. H.; Stitt, M. S.; Jonnalagadda, V. S.; Rugo, R. E.; 
Kerrison, G. F.; Engelward, B. P. Proc. Natl. Acad. Sci. U. S. A. 2003, 11, 6325-
6330. 
46.  Moore, I.; Murphy, A. Plant Cell 2009, 6, 1632-1636. 
47.  Di Maria, F.; Palama, I. E.; Baroncini, M.; Barbieri, A.; Bongini, A.; Bizzarri, R.; 
Gigli, G.; Barbarella, G. Org. Biomol. Chem. 2014, 10, 1603-1610. 
48.  Lavis, L. D.; Raines, R. T. ACS Chem. Biol. 2014, 4, 855-866. 
49.  Giloh, H.; Sedat, J. W. Science 1982, 4566, 1252-1255. 
50.  Hoebe, R. A.; Van Oven, C. H.; Gadella, T. W. J., Jr.; Dhonukshe, P. B.; Van 
Noorden, C. J. F.; Manders, E. M. M. Nat. Biotechnol. 2007, 2, 249-253. 
51.  Berrios, M.; Conlon, K.; Colflesh, D. Confocal Microscopy 1999, 55-79. 
	  22	  
	  
52.  Cordes, T.; Maiser, A.; Steinhauer, C.; Schermelleh, L.; Tinnefeld, P. Phys. Chem. 
Chem. Phys. 2011, 14, 6699-6709. 
53.  Jamur, M. C.; Oliver, C. Methods Mol. Biol. 2010, 63-66. 
54.  Pan, D.; Hu, Z.; Qiu, F.; Huang, Z.; Ma, Y.; Wang, Y.; Qin, L.; Zhang, Z.; Zeng, 
S.; Zhang, Y. Nat. Commun. 2014, 5573. 
55.  Singh, M.; Jadaun, G. P. S.; Ramdas; Srivastava, K.; Chauhan, V.; Mishra, R.; 
Gupta, K.; Nair, S.; Chauhan, D. S.; Sharma, V. D.; Venkatesan, K.; Katoch, V. M. 
Indian J. Med. Res. 2011, 5, 535-540. 
56.  Purschke, M.; Rubio, N.; Held, K. D.; Redmond, R. W. Photochem. Photobiol. Sci. 
2010, 12, 1634-1639. 
57.  Tinevez, J.; Dragavon, J.; Baba-Aissa, L.; Roux, P.; Perret, E.; Canivet, A.; Galy, 
V.; Shorte, S. Methods Enzymol. 2012, Imaging and Spectroscopic Analysis of 
Living Cells, 291-309. 
58.  Lacivita, E.; Leopoldo, M.; Berardi, F.; Colabufo, N. A.; Perrone, R. Curr. Med. 
Chem. 2012, 28, 4731-4741. 
59.  Lee, H.; Akers, W.; Bhushan, K.; Bloch, S.; Sudlow, G.; Tang, R.; Achilefu, S. 
Bioconjug. Chem. 2011, 4, 777-784. 
60.  Greenspan, P.; Mayer, E.; Fowler, S. J. Cell Biol. 1985, 3, 965-973. 
61. Raymo, F. M. Phys. Chem. Chem. Phys. 2013, 36, 14840-14850. 
62.  Grimm, J. B.; Heckman, L. M.; Lavis, L. D. Fluorescence-Based Biosensors: from 
Concepts to Applications 2013, 1-34. 
63.  Rust, M. J.; Bates, M.; Zhuang, X. Nat. Methods 2006, 10, 793-795. 
64.  Betzig, E.; Patterson, G. H.; Sougrat, R.; Lindwasser, O. W.; Olenych, S.; 
Bonifacino, J. S.; Davidson, M. W.; Lippincott-Schwartz, J.; Hess, H. F. Science 
2006, 5793, 1642-1645. 
65.  Hess, S. T.; Girirajan, T. P. K.; Mason, M. D. Biophys. J. 2006, 11, 4258-4272. 
66.  Patterson, G.; Lippincott-Schwartz, J. Science 2002, 5588, 1873-1877. 
67.  Kobayashi, T.; Komatsu, T.; Kamiya, M.; Campos, C.; Gonzalez-Gaitan, M.; Terai, 
T.; Hanaoka, K.; Nagano, T.; Urano, Y. J. Am. Chem. Soc. 2012, 27, 11153-11160. 
	  23	  
	  
68.  Lord, S. J.; Conley, N. R.; Lee, H. D.; Samuel, R.; Liu, N.; Twieg, R. J.; Moerner, 
W. E. J. Am. Chem. Soc. 2008, 29, 9204-9205. 
69.  Yu, Z.; Ho, L. Y.; Lin, Q. J. Am. Chem. Soc. 2011, 31, 11912-11915. 
70.  Ando, R.; Hama, H.; Yamamoto-Hino, M.; Mizuno, H.; Miyawaki, A. Proc. Natl. 
Acad. Sci. U. S. A. 2002, 20, 12651-12656. 
71.  Maurel, D.; Banala, S.; Laroche, T.; Johnsson, K. ACS Chem. Biol. 2010, 5, 507-
516. 
72.  Carlson, A. L.; Fujisaki, J.; Wu, J.; Runnels, J. M.; Turcotte, R.; Lo Celso, C.; 
Scadden, D. T.; Strom, T. B.; Lin, C. P. Plos One 2013, 8, e69257. 
73.  Chozinski, T. J.; Gagnon, L. A.; Vaughan, J. C. FEBS Lett. 2014, 19, 3603-3612. 
74.  Assadi, N.; Pogodin, S.; Cohen, S.; Agranat, I. Struct. Chem. 2015, 1, 319-352. 
75.  Biedermann, P.; Stezowski, J.; Agranat, I. Chem. Commun. 2001, 11, 954-955. 
76.  Pogodin, S.; Suissa, M. R.; Levy, A.; Cohen, S.; Agranat, I. Eur. J. Org. Chem. 
2008, 17, 2887-2894. 
77.  Biedermann, P.; Stezowski, J.; Agranat, I. Eur. J. Org. Chem. 2001, 1, 15-34. 
78.  Levy, A.; Biedermann, P.; Cohen, S.; Agranat, I. J. Chem. Soc., Perkin Trans. 2 
2000, 725-735. 
79.  Biedermann, P.; Stezowski, J.; Agranat, I. Chem. Eur. J. 2006, 12, 3345-3354. 
80.  Fang, X.; Jiyan, P.; Bingtai, L.; Jiajun, W.; Yi, Z.; Zhigang, S.; Vrijmoed, L. L. P.; 
Gareth, J. E. B.; Yongcheng, L. Chin. J. Chem. 2009, 2, 365-368. 
81.  Rarig, R. F.; Tran, M. N.; Chenoweth, D. M. J. Am. Chem. Soc. 2013, 24, 9213-
9219. 
82.  Tran, M. N.; Rarig, R. F.; Chenoweth, D. M. Chem. Sci. 2015, 8, 4508-4512. 
83.  Tran, M. N.; Chenoweth, D. M. Angew. Chem. , Int. Ed. 2015, 22, 6442-6446. 
 	  
	  
	  
	  24	  
	  
	  
	  
	  
	  
	  
	  
	  
 
 
Chapter 2 : Synthesis and Conformational Dynamics of the Reported Structure of 
Xylopyridine A 
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2.1 Introduction 
For more than 50 years, natural products have provided a rich source for the 
discovery of nucleic acid binding molecules, some of which have made far reaching 
impacts in human medicine ranging from cancer chemotherapy to infectious diseases.1−10 
Despite half a century of research, our ability to design small molecules to target nucleic 
acids in a structure- and sequence-specific manner, beyond the two primary modes of 
recognition (i.e., intercalation and groove binding) is still in its infancy.1−14 Targeting 
DNA and RNA motifs in a structure- and sequence-selective manner allows for small 
molecule control over cellular events and could provide fundamental insight into 
biological processes, paving the way for new therapeutic strategies. The development of 
structure- and sequence-specific small molecule nucleic acid binders represents an 
important challenge at the frontier of chemical biology, where natural products have 
historically served as inspiration.1−14 
Xylopyridine A, a dimeric azaxanthone isolated in 2009 from the mangrove 
fungus Xylaria sp. (#2508), was reported as compound (E)-1 (Figure 2.1a) and was found 
to have potent B-form DNA binding ability.15−19 Xanthones and azaxanthones are 
prevalent in natural products, have been shown to bind DNA, and have a rich history in 
medicinal chemistry with applications in a wide range of therapeutic areas, such as 
cancer, cardiovascular disease, and infectious diseases.20−22 Despite this prevalence, the 
dixanthilidene (reductively dimerized xanthone) architectures have remained elusive in 
nature until recently.15−19 The reported diazaxanthilidene structure for xylopyridine A was 
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primarily established using NMR spectroscopy, and its reported optical rotation implied a 
configurationally stable helically chiral conformation, originally assigned as E-twisted on 
the basis of AM1 calculations.15 Xylopyridine A was also reported to be emissive, a 
property used to establish DNA binding using direct fluorimetric titration.15 The 
combination of unprecedented natural product architecture, nucleic acid binding ability, 
and unique conformational properties makes xylopyridine A an important target for 
synthesis and structural investigations. Motivated by these unique aspects and the 
possibility of accessing xylopyridine A derivatives, we initiated synthetic studies to shed 
light on this novel class of nucleic acid binder. 
 
Figure 2.1a. Chemical structure reported for xylopyridine A. 
 
Here, we report the synthesis of the proposed structure for xylopyridine A and 
show that (E)-1 is in fact a conformationally dynamic structure with an isomerization 
barrier accessible at room temperature. X-ray crystallography revealed an anti-folded 
conformation in the solid state (Figure 2.1c), while DFT calculations and variable 
temperature NMR studies support a dynamic equilibrating mixture of olefin isomers in 
solution. Experimental and computational UV-vis spectroscopy data support the 
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minimum energy conformer as anti-folded in the solid state and in solution. We show 
that the structure proposed in the original report of xylopyridine A is not consistent with 
our analytical data and its true identity remains unresolved. Furthermore, we show that 
the structure proposed for xylopyridine A is not capable of B-form DNA binding. Despite 
the inability of (E)-1 to bind B-form DNA, we find that a simple modification produces a 
new class of structure-specific G-quadruplex binding scaffold that exhibits near perfect 
specificity over B-form DNA binding. 
 
Figure 2.1b. Relative ground-state free energies of compound 1 conformers. Basis set = 6-
311+G(2d,p). 
 
 
	  
Figure 2.1c. X-ray crystal structure of diazaxanthilidene (E)-1. 
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2.2 Results and Discussion 
Prior to initiating synthetic investigations, we used DFT calculations to compare the 
ground-state structures of the most stable conformers of xylopyridine A (E)-1 and its Z 
isomer (Z)-1.23 The ground-state structures are shown in Figure 2.1b, with relative 
energies using two well-established DFT functionals. Our calculations predict that the E-
anti-folded conformation is the most stable (0.0 kcal/mol), with the Z-anti-folded 
conformation very close in energy (0.5-0.6 kcal/mol). Interestingly, the twisted 
conformation in both the E and Z isomers is higher in energy by 4.8-6.0 kcal/mol relative 
to the anti-folded conformers. Based on these calculations, indicating the possibility of an 
E/Z mixture in an anti-folded conformation, we initiated our synthetic studies.  
 
Scheme 2.1. Synthesis of the reported structure of Xylopyridine A. 
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Given the symmetric nature of xylopyridine A, we envisioned a rapid synthesis of 
(E)-1/(Z)-1 via reductive homodimerization of 3-azaxanthone 4 (Scheme 2.1). Our 
synthesis began with chlorination of commercially available 4-cyanopyridine 2 via 
lithiation with LiTMP and subsequent treatment with hexachloroethane in THF to afford 
3-chloro-4-cyanopyridine. The chloride was displaced using sodium phenoxide in DMF 
to provide biaryl ether 3, which was heated to 210 °C in polyphosphoric acid to provide 
azaxanthone 4 in 56% yield over three steps. Neither McMurry conditions nor Woollins 
reagent effected efficient homodimerization of 4. Lawesson's reagent was employed to 
convert 4 to its corresponding thione 5 in 97% yield.24 Homodimerization of thione 5 was 
effected by reductive coupling using copper powder in refluxing toluene25 to afford 1 as a 
1.1:1.0 mixture of E and Z isomers in 75% yield (Scheme 2.1). The yield over five steps 
for (E)-1/(Z)-1 was 41%.  
The isomeric mixture of (E)-1/(Z)-1 was inseparable by normal phase, reverse phase, 
and supercritical fluid chromatography. The mixture was characterized by mass 
spectrometry (MS), differential scanning calorimetry (DSC), and NMR, UV-vis, 
fluorescence, and IR spectroscopy. To our surprise, only our MS data were consistent 
with the characterization data reported for xylopyridine A.15 The melting point reported 
for xylopyridine A was 200-202 °C;15 however, using DSC, we found the melting point 
of crystalline (E)-1 to be 327 °C, with decomposition observed above 330 °C. A direct 
NMR comparison was not viable due to the insolubility of (E)-1 in acetone-d6 at room 
temperature. To verify the identity of our dimerization product, single crystals were 
obtained by slow evaporation from CHCl3/CH3CN. X-ray data confirmed the structure as 
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(E)-1 and revealed the anti-folded conformation (E)-1-af (Figure 2.1c), which is 
consistent with the relative ground-state energies from DFT calculations (Figure 2.1b). 
Dissolving crystals of (E)-1 at –10 °C provided a 1H NMR spectrum identical to that of 
the isomeric mixture, indicating isomer equilibration on an experimentally relevant time 
scale. 
 
Figure 2.2. Variable-temperature NMR spectroscopy of (E)-1/(Z)-1. Dynamic NMR showing the 
temperature-dependent exchange process between isomers (E)-1 and (Z)-1. Variable-temperature 
NMR experiments conducted in DMF-d7. 
 
Variable-temperature 1H NMR spectroscopy was used to investigate the dynamic 
relationship between (E)-1 and (Z)-1 (Figure 2.2).26 Cooling the sample to –30 °C 
resulted in sharpening of unresolved doublets at δ 8.26, indicating negligible exchange on 
the NMR time scale. These doublets are assigned to the pyridine ring and correspond to 
hydrogens at the 7 and 7' positions (Figure 2.1a). Incremental heating up to 50 °C led to 
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signal broadening indicating slow exchange on the NMR time scale. Further heating to 
100 °C provided a significantly sharpened spectrum due to fast exchange (Figure 2.2). 
With a decoupling pulse (3610 Hz) at room temperature, the two doublets at δ 8.26 
became two singlets spaced 31.7 Hz apart. Repeating the heating regimen while 
decoupling allowed for clearer observation of coalescence at 45 °C (kexchange = 70.4 s-1) 
and fast exchange at 70 °C. From the temperature dependent NMR data, the activation 
energy for the (E)-1/(Z)-1 isomerization was determined to be ΔG⧧ = 15.9 kcal/mol. 
 
Figure 2.3a. Absorption spectrum overlaid with results from excited state calculations of 1. All 
excited state calculations were performed with the 6-311+G(2d,p) basis set. The height of each 
marker corresponds to the oscillator strength at each level of theory. Results for both (E)-1 and 
(Z)-1, at each level of theory, were less than 0.29 eV (2.4 nm) apart and appear as coincidental 
lines on the plot above. Absorption data were collected at 23 °C using CHCl3 as the solvent, Abs 
λmax = 375 nm (ε = 16,659 ± 86 M-1 cm-1).  
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Figure 2.3b. Emission and excitation spectra of (E)-1/(Z)-1 in CHCl3. Emission λmax = 435 nm, 
excitation λmax = 378 nm, quantum yield Φ = 0.088 ± 0.002. 
 
Having established the solid-state structure as the achiral anti-folded conformation 
and the feasibility of a dynamic isomerization process even below room temperature (≤10 
°C), we focused our attention on the conformational preference in solution. At this point, 
all of the data suggested an interconverting mixture of E/Z isomers in solution. The issue 
of twisted versus anti-folded in solution remained, and we addressed it using a 
combination of UV-vis spectroscopy and excited state computational methods.27−31 The 
experimentally determined absorbance spectrum for (E)-1/(Z)-1 shows a featureless band 
in CHCl3 with a single maximum at λmax = 375 nm (ε = 16,659 ± 86 M-1 cm-1). This is in 
stark contrast to the reported UV-vis of xylopyridine A, which shows a band with 
vibronic structure and maxima at λabs = 376, 398 (λmax), and 425 nm.15 The possibility of 
a twisted conformation in solution was evaluated using excited state calculations to 
simulate the UV-vis spectrum.32 
Using various levels of theory we were able to bound our experimental result and 
make a reasonable prediction regarding the presence of the twisted conformation (Figure 
2.3a). Levels of theory that span a range of accuracy from overestimating (i.e., CIS)33,34 
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to underestimating (i.e., LSDA),33,34 in addition to putatively more accurate hybrid 
methods such as B3LYP,35,36 M06,37 and range-separated functionals such as ωB97X-
D38 were chosen. Results from theoretical calculations predict the absorption spectrum 
for the anti-folded isomers to be coincidental and centered (at 377 nm) between 4.2 and 
2.7 eV (292 and 462 nm). The twisted conformation is predicted to be red-shifted 
compared to the anti-folded conformation by a mean value of nearly 1.6 eV (295 nm) to a 
range between 555 and 758 nm. Neither the UV absorbance of our synthesized compound 
(375 nm) nor the λmax of the previously reported species (398 nm) approaches the lower 
limit (red bounding box, Figure 2.3) of the calculated absorbance for the twisted 
conformation (587 nm). In contrast to the anti-folded isomers, the E and Z forms of the 
twisted conformation are theoretically differentiated, with the Z form predicted to be red-
shifted by 0.1 eV (30 nm). Taken together, UV-vis spectroscopy and excited state 
calculations support a preference for the anti-folded conformation in solution. Excitation 
and emission spectra are shown in Figure 2.3b, and the quantum yield of (E)-1/(Z)-1 in 
CHCl3 was found to be Φ = 0.088 ± 0.002. 
 
Figure 2.4a. Chemical structure of the (E)-6/(Z)-6. 
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Figure 2.4b. Equilibrium dialysis experiments of (E)-6/(Z)-6 with CT-DNA and telomeric DNA. 
Telomeric DNA sequence is 5'-AGGG(TTAGGG)7-3'. Cb is the bound ligand concentration, and 
Cf is the free ligand concentration. 
 
Xylopyridine A was reported to bind CT-DNA,15 by intercalation. We found that the 
structure reported as xylopyridine A (E)-1/(Z)-1 did not bind CT-DNA, although 
solubility was a major impediment in a variety of neutral-to acidic buffers. Treatment of 
(E)-1/(Z)-1 with dimethyl sulfate in toluene led to water-soluble N-methylpyridinium 
analogues (E)-6/(Z)-6 (Figure 2.4a), facilitating nucleic acid binding studies using the 
equilibrium dialysis method pioneered by Chaires et al.39−41 The methylated analogues 
(E)-6/(Z)-6 did not bind CT-DNA; however, binding was observed for the human 
telomeric sequence (Figure 2.4b), demonstrating that the anti-folded diazaxanthilidene 
architecture can selectively bind quadruplex forming nucleic acid sequences over B-form 
DNA. This level of selectivity is dramatic compared to the commonly used commercially 
available quadruplex binder TMPyP4 (cationic porphyrin, 5,10,15,20-tetra(N-methyl-4-
pyridyl)porphyrin), which only shows a 2.5-fold selectivity for binding telomeric DNA 
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over B-form DNA. Despite considerable debate over the existence and relevance of 
quadruplexes in vivo, mounting evidence is pointing toward quadruplex nucleic acids as 
an emerging oncology target.42,43 Recently, using structure-specific antibodies as probes, 
Balsubramanian et al. reported results consistent with the observation of quadruplexes in 
human cells.44 
 
Figure 2.5a. Crystal structure of (E)-1. The folding angle between the phenyl and the pyridyl 
planes of each tricyclic system is 144°. 
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Figure 2.5b. Crystal structure of cryptolepine. Cryptolepine is an intercalator having a planar 
structure with a height of h = 3.4 Å. 
 
The lack of affinity for B-form DNA can be attributed to the lack of planarity caused 
by the overcrowded anti-folded molecular architecture of (E)-6/(Z)-6. Intercalators are 
generally planar polyaromatic molecules as exemplified by cryptolepine,45 which can 
effectively stack against base-pairs via π-π stacking interactions. The local unwinding of 
the nucleic acid helix at an intercalation site results in a translation of the base-pairs along 
the helix axis a distance equal to the height of an aromatic ring (h ≈ 3.4 Å, Figure 2.5b). 
The anti-folded alignment of the nonplanar three-ring systems in (E)-6/(Z)-6 results in a 
molecular geometry with a height of 5.8 Å, compared to a height of 3.4 Å for a standard 
intercalator. Within each tricyclic system of the anti-folded conformer there is an angle of 
144° between the corresponding phenyl and pyridyl planes (Figure 2.5a). This 
conformation lacks a continuous planar π surface that extends beyond a single six-
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membered ring, limiting its ability for effective π-π interactions. The specific stabilizing 
effects that account for the binding of (E)-6/(Z)-6 with telomeric DNA remain to be 
determined. However, such specificity compared to B-form DNA binding suggests that 
this scaffold could serve as a starting point for the design of quadruplex-specific ligands 
with a novel architecture that locks out nonspecific intercalative binding modes. Future 
studies focused on targeting unique quadruplex topologies with this new scaffold will be 
of considerable interest, given its novel architecture. 
2.3 Conclusions 
In summary, the reported structure of xylopyridine A (E)-1 has been synthesized 
and found to have a low isomerization barrier, allowing for equilibration with its Z 
isomer in solution on an experimentally relevant time scale (kexchange = 70.4 s-1 at 45 °C). 
Using a combination of experiment and theory, the preferred conformation in solution 
and the solid state was determined to be anti-folded. While the identity of xylopyridine A 
remains unresolved, the synthesis of (E)-1/(Z)-1 has provided a new molecular scaffold 
for investigating structure-specific nucleic acid binders. The ability to exclude 
nonspecific B-form DNA intercalation while maintaining affinity for guanine tetrads will 
be key to the field of quadruplex structure-specific nucleic acid targeting. In depth studies 
of this new class of conformationally dynamic structure-specific nucleic acid binding 
scaffold are underway and more details will be reported in due course. 
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2.4 Material and Methods 
General Information:  
n-Butyllithium in hexanes was purchased from Acros and titrated using 
diphenylacetic acid recrystallized from toluene. All salts used for equilibrium dialysis 
were purchased from Fisher Bioreagents. The telomeric DNA (5'-AGG GTT AGG GTT 
AGG GTT AGG GTT AGG GTT AGG GTT AGG GTT AGG G-3') was purchased from 
Integrated DNA Technologies. All other reagents were purchased from Sigma Aldrich 
and used without further purification. Reactions requiring anhydrous conditions were run 
under argon, using Fisher solvents dried via alumina column. Silica chromatography was 
done using Silicycle silica gel (55−65 Å pore diameter). Thin-layer chromatography was 
performed using Sorbent Technologies silica plates (250 µm thickness). 
1H and 13C NMR spectra were recorded at 500 and 125 MHz, respectively, on a 
Bruker UNI 500 NMR. High-resolution mass spectra were obtained by Dr. Rakesh Kohli 
at the University of Pennsylvania Mass Spectrometry Service Center on a Micromass 
AutoSpec electrospray/chemical ionization spectrometer. X-ray diffraction structure 
determination was performed by Dr. Patrick Carroll at the University of Pennsylvania. 
Infrared spectra were obtained on a Perkin-Elmer BX FT-IR spectrometer. Ultraviolet 
absorption spectrophotometry was performed on a JASCO V-650 spectrophotometer with 
a PAC-743R multichannel Peltier using quartz cells with 1 cm cell path lengths. DSC 
was performed on a TA Instruments Q 2000 differential scanning calorimeter. Reverse-
phase column chromatography was performed using a Teledyne Isco CombiFlash Rf 
system on RediSep Rf Gold C18 columns. High performance liquid chromatography 
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analysis was carried out using a Jasco HPLC instrument equipped with a Phenomenex 
column (Luna 5u C18(2) 100A; 250 x 4.60 mm, 5 µm). Equilibrium dialysis experiments 
were performed in a Thermo Scientific Pierce RED plate with 8K molecular-weight 
cutoffs. 
All calculations were performed using Gaussian 09. All local minima were 
optimized in the gas phase using DFT-B3LYP and M06 methods with the 6-311+G(2d,p) 
basis set; they were then confirmed to be stable and to have no imaginary frequencies by 
stability and frequency calculations, respectively, using the same basis set. All UV-vis 
calculations were performed using CIS, TD-ωB97X-D, TD-B3LYP, TD-PBEPBE, TD-
M06, and TD-LSDA methods with the same basis set in chloroform. 
 
Synthesis: 
 
4-Cyano-3-phenoxypyridine (3). In a 50 mL round-bottom flask, phenol (0.809 
g, 8.6 mmol) and cesium carbonate (1.645 g, 5.0 mmol) were taken up in DMF (10 mL) 
and treated with neat sodium hydride (0.339 g, 8.5 mmol). After hydrogen evolution 
ceased, 3-chloro-4-cyanopyridine46 (0.583 g, 4.2 mmol) was added neat, and the reaction 
mixture was stirred at 50 °C for 36 h. Solvent was removed under vacuum, and the crude 
product was transferred to a separatory funnel with 25 mL of water and 25 mL CHCl3. 
The aqueous layer was extracted with CHCl3 (three times, 25 mL). The organic layers 
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were combined, washed with 40 mL of 2 N NaOH, dried over MgSO4, concentrated in 
vacuo, and purified by silica gel chromatography (1:4 EtOAc:hexanes) to provide 4-
cyano-3-phenoxypyridine47 3 as a colorless oil (0.604 g, 3.1 mmol, 73%). 1H NMR (500 
MHz, CDCl3): δ (ppm) 8.46 (1H, d, J = 5 Hz), 8.33 (1H, s), 7.53 (1H, d, J = 5 Hz), 7.46 
(2H, dd, J = 7, 9 Hz), 7.28 (1H, t, J = 7 Hz), 7.12 (2H, d, J = 9 Hz). 
 
 
3-Aza-9H-xanthen-9-one (4). Procedure I. Polyphosphoric acid (9.701 g, excess) 
was added to a beaker containing 4-cyano-3- phenoxypyridine 347 (0.202 g, 1.0 mmol), 
and the reaction was stirred at 225 °C for 6 h. The reaction was allowed to cool before 
being diluted with 200 mL of water and slowly basified to pH 7 with solid NaOH. The 
mixture was transferred to a separatory funnel with 50 mL of DCM, and the aqueous 
layer was extracted with DCM (three times, 50 mL). The organic layers were combined, 
dried over MgSO4, concentrated in vacuo, and purified by silica gel chromatography (3:7 
EtOAc:hexanes) to provide 3-azaxanthone 448 as a white solid (0.1679 g, 0.85 mmol, 
83%). IR (neat, cm-1): 1682, 1417, 761. 1H NMR (500 MHz, CDCl3): δ (ppm) 9.01 (1H, 
s), 8.62 (1H, d, J = 5 Hz), 8.29 (1H, dd, J = 1.5, 8 Hz), 8.06 (1H, d, J = 5 Hz), 7.82−7.72 
(1H, m), 7.575 (1H, d, J = 8.5 Hz), 7.40 (1H, t, J = 7.5 Hz). 13C NMR (126.9 MHz, 
CDCl3): δ (ppm) 176.6, 156.2, 151.2, 144.5, 142.7, 136.2, 127.1, 126.4, 125.0, 122.4, 
118.8, 118.5. HRMS (m/z): [M + H]+ calcd for C12H7NO2, 198.0555; found, 198.0559. 
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3-Aza-9H-xanthen-9-one (4). Procedure II. A round-bottom flask was charged 
with 2,2,6,6-tetramethylpiperidine (3.50 mL, 20.7 mmol) and THF (40 mL). The solution 
was cooled to –30 °C under argon and then treated with 2.38 M n-butyllithium in hexanes 
(8.34 mL, 19.8 mmol). The solution was allowed to warm to 0 °C and stir for 30 min 
before being cooled back down to –78 °C. A solution of 4- cyanopyridine 2 (1.030 g, 9.9 
mmol) in THF (20 mL) was added over 15 min via a syringe pump. After 30 min of 
stirring at –78 °C, a solution of hexachloroethane (5.000 g, 21.1 mmol) in THF (10 mL) 
was added over 15 min. After 30 min of stirring at –78 °C, the solution was warmed to 
room temperature, quenched with saturated NH4Cl (40 mL), and extracted with ethyl 
acetate. The combined organic layers were washed with brine, dried over Na2SO4, 
concentrated in vacuo, and run through a short silica plug using 1:1 EtOAc:hexanes to 
provide crude 3-chloro-4-cyanopyridine46 (1.196 g). Forty-two percent of this crude 
product was carried on to the next step. 
Phenol (0.692 g, 7.4 mmol), NaH 60% dispersion in mineral oil (0.296 g, 7.4 
mmol), Cs2CO3 (1.242 g, 3.8 mmol), and DMF (8 mL) were stirred under argon at room 
temperature. When the bubbling stopped, a solution of the above crude product (0.507 g) 
in 1 mL of DMF was added, and then rinsed with 1 mL of fresh DMF. After being stirred 
at 50 °C for 2.5 days, the reaction mixture was allowed to cool to room temperature, 
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quenched with saturated NH4Cl, and extracted with DCM. The extract was washed with 
brine, dried with Na2SO4, and then concentrated in vacuo to give a brown oil (1.137 g). 
This oil was transferred to a beaker using a small amount of DCM. After the DCM was 
removed by stirring at 40 °C, 45 g of polyphosphoric acid was added, and the mixture 
was stirred at 210 °C overnight. Next, the solution was cooled to room temperature, 
poured over ice water, and neutralized slowly with concentrated NaOH. The resulting 
mixture was filtered through celite and washed with water followed by DCM. The 
aqueous layer was extracted with DCM. The combined organic layers were washed with 
brine, dried over Na2SO4, and evaporated under reduced pressure to afford 3-
azaxanthone48 4 as a white solid (0.463 g, 2.3 mmol, 56% over three steps). 
 
 
3-Aza-9H-xanthene-9-thione (5). A mixture of 3-azaxanthone 4 (1.004 g, 5.1 
mmol) and Lawesson's reagent (1.257 g, 3.1 mmol) in a 250 mL round-bottom flask was 
dried at 40 °C under high vacuum for 1 h, and then the flask was back-filled with argon. 
The mixture was taken up in 160 mL of alumina-dried toluene, heated to 80 °C, and 
stirred for 18 h. The reaction was concentrated in vacuo, and the crude product was 
purified by silica gel chromatography (15:85 EtOAc:hexanes) to provide thione 5 as a 
green solid (1.052 g, 4.9 mmol, 97%). IR (neat, cm-1): 1415, 1330. 1H NMR (500 MHz, 
CDCl3): δ (ppm) 9.02 (1H, s), 8.62 (1H, d, J = 8 Hz), 8.55 (1H, d, J = 5 Hz), 8.35 (1H, d, 
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J = 5 Hz), 7.8 (1H, t, J = 8 Hz), 7.52 (1H, t, J = 4 Hz), 7.39 (1H, t, J = 8 Hz). 13C NMR 
(126.9 MHz, CDCl3): δ (ppm) 176.6, 156.2, 151.2, 144.5, 142.7, 136.2, 127.1, 126.4, 
125.0, 122.4, 118.7, 118.5. HRMS (m/z): [M + H]+ calcd for C12H7NOS, 214.0327; 
found, 214.0327. 
 
 
 (E/Z)-3,3'-Diazaxanthilidene ((E)-1/(Z)-1). Copper powder (5.133 g, 80.8 
mmol) was suspended in toluene (80 mL), 75 mL of which was distilled off to remove 
water. The distillation apparatus was replaced with a reflux condenser, and the apparatus 
was flushed with argon before a solution of thione 5 (0.516 g, 2.4 mmol) in 20 mL of 
toluene was cannulated into the copper suspension. The resulting mixture was heated to 
120 °C and stirred for 20 h. The mixture was then gravity filtered, rinsing the copper with 
80 °C toluene (100 mL) and boiling CHCl3 (100 mL). The organic fractions were 
combined, concentrated to dryness, dissolved in the minimum volume of boiling CHCl3, 
cooled to room temperature, treated with Et2O (45 mL), and placed in a 4 °C refrigerator 
for 16 h. Yellow crystalline 3,3'-diazaxanthilidene (E)-1/(Z)-1 (0.198 g, 0.6 mmol, 45%) 
was recovered via Buchner funnel filtration and rinsing with Et2O. Purification of the 
mother liquor by silica gel chromatography (3:2 EtOAc:hexanes) provided additional 
3,3'-diazaxanthilidene (E)-1/(Z)-1 (0.134 g, 0.4 mmol, 30%) as a yellow powder. IR 
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(neat, cm-1): 1410, 1205, 756. 1H NMR (500 MHz, acetone-d6): δ 8.69 and 8.68 (4H, 
overlapping singlets), 8.23 and 8.20 (4H, overlapping doublets, J = 5 and 5 Hz), 7.46-
7.40 (8H, m), 7.26-6.99 (12H, m). 1H NMR (500 MHz, CDCl3): δ (ppm) 8.71 and 8.70 
(4H, overlapping singlets), 8.21 and 8.17 (4H, overlapping doublets, J = 5 and 5 Hz), 
7.38-7.29 (8H, m), 7.19-7.13 (4H, m), 7.07-7.04 (4 H, m), 7.00-6.92 (4H, m). 1H NMR 
(500 MHz, DMF-d7): δ (ppm) 8.75 (4H, bs), 8.29-8.20 (4H, m), 7.52-7.42 (8H, m), 7.28-
7.00 (12H, m). 1H NMR (500 MHz, 3:1 DMF-d7: F3CCO2D): δ (ppm) 9.35 (4H, bs), 6.9 
(4H, dd, J = 5.5, 11 Hz), 8.13 (2H, d, J = 5.5 Hz), 7.87 (2H, d, J = 6 Hz), 7.59−7.49 (8H, 
m), 7.45 (2H, d, J = 8 Hz), 7.29 (2H, d, J = 8 Hz), 7.18−7.12 (4H, m). 13C NMR (126.9 
MHz, CDCl3): δ (ppm) 162.2, 162.0, 154.8, 154.6, 138.7, 138.2, 138.2, 137.7, 135.2, 
134.1, 131.6, 131.3, 128.3, 128.0, 125.1, 124.7, 124.5, 122.9, 122.9, 121.3, 120.8, 18.0, 
117.8. HRMS (m/z): [M + H]+ calcd for C24H14N2O2, 363.1134; found, 363.1122. 
 
 
(E/Z)-N-Methyl-3,3'-diazaxanthilidene ((E)-6/(Z)-6). In a two-necked round-
bottom flask, 3,3'-diazaxanthilidene (E)-1/(Z)-1 (0.041 g, 0.11 mmol) was suspended in 
toluene (20 mL). Next, a solution of dimethyl sulfate 1% in toluene (0.53 mL, 0.055 
mmol) was slowly added. After a 12 h reflux, the mixture was charged with another batch 
of dimethyl sulfate 1% in toluene (0.53 mL, 0.055 mmol) and refluxed for 24 h before 
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cooling to room temperature. The mixture was filtered, and the solid was washed several 
times with toluene and then dissolved in water. The desired product was isolated as a 
yellow solid using reverse phase column chromatography with 0.1% TFA/water and 
acetonitrile as eluents (0.030 g, 0.06 mmol, 55%). IR (neat, cm-1): 1693, 1200. 1H NMR 
(500 MHz, D2O): δ (ppm) 9.06 and 9.03 (2H, overlapping singlets), 8.91 (2H, s), 8.41-
8.31 (4H, m), 7.82−7.66 (4H, m), 7.62-7.49 (8H, m), 7.35-7.22 (4H, m), 7.22-7.10 (4H, 
m), 4.45 and 4.43 (6H, overlapping singlets). 13C NMR (126.9 MHz, D2O): δ (ppm) 
163.1 163.1, 162.8, 162.6, 162.3, 154.1, 153. 8, 153.8, 153.4, 153.1, 152.4, 152.4, 152.4, 
152.3, 139.5, 1 39.2, 139.0, 138.6, 138.5, 137.8, 138.8, 136.7, 136.5, 135.1, 134.0, 131.8, 
131.8, 131.3, 127.5, 127.4, 127.3, 125.4, 12 5.2, 125.0, 124.9, 124.8, 124.6, 123.9, 123.1, 
123.0, 121.8, 121.3, 120.0, 120.0, 119.4, 119.4, 118.0, 117.6, 117.6, 117. 5, 115.3, 48.2, 
48.1. HRMS (m/z): [M]+ calcd for C25H17N2O2+, 377.1290; found, 377.1286. 
 
Equilibrium Dialysis Experiments. All experiments were carried out in 
triplicate using a buffer containing 6 mM Na2HPO4, 2 mM NaH2PO4, 1 mM Na2EDTA, 
and 200 mM NaCl (pH 7). The concentrations of ligand ((E)-6/(Z)-6) and nucleic acids 
were determined by UV spectroscopy (260 nm for CT-DNA and telomeric DNA and 410 
nm for the ligand). 
CT-DNA was dissolved in buffer, followed by dilution to 100 µM (calculated in 
terms of base pairs). Telomeric DNA was dissolved in buffer, heated to 90 °C, cooled 
slowly to room temperature, and diluted to 30 µM (in terms of G-quartets). The ligand 
was dissolved in buffer and diluted to 8 µM. 
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For each experiment, 500 µL of nucleic acid solution was added to the sample 
chamber, and 750 µL of ligand solution was added to the buffer chamber. The 
equilibrium dialysis plate was then covered with a sealing film and incubated at room 
temperature for 24 h. After incubation, 360 µL of each sample was added to 40 µL of 
10% SDS and measured by UV spectroscopy to determine the concentrations of nucleic 
acids and ligands. Appropriate corrections were made for the dilution resulting from the 
addition of SDS solution. The free ligand concentration (Cf) was obtained from the buffer 
chamber, while the total ligand concentration (Ct) was determined from the sample 
chamber. The bound ligand concentration (Cb) was then calculated: Cb = Ct − Cf. The 
concentration of nucleic acids was also determined from the sample chamber. The ratio 
Cb/Cf was divided by the concentration of nucleic acids in term of monomeric units (base 
pairs for CT-DNA and quartets for telomeric DNA). The obtained values were then 
plotted to demonstrate the selectivity of ligand toward telomeric DNA. 
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2.7 Spectra and supplemental information 
Coordinates of the DFT-B3LYP stationary points 
E-anti-folded 
 
C 0.670038 0.017766 0.117968 
C -0.669974 -0.017766 -0.118032 
C -1.478406 -1.255484 -0.234032 
C -1.146812 -2.4176 -0.936032 
C -2.022187 -3.491295 -0.931032 
H -1.773504 -4.400381 -1.470032 
N -3.194187 -3.491886 -0.283032 
C -3.547797 -2.374762 0.341968 
C -2.741401 -1.241043 0.360968 
O -3.231005 -0.104872 0.960968 
C -2.817593 1.075983 0.375968 
C -3.707221 2.142294 0.392968 
C -3.368812 3.314176 -0.267032 
C -2.159781 3.400754 -0.959032 
C -1.269152 2.338443 -0.940032 
C -1.557561 1.166544 -0.229032 
H -0.334125 2.415117 -1.478032 
H -1.913468 4.297668 -1.512032 
H -4.059521 4.147417 -0.270032 
H -4.659262 2.024626 0.893968 
H -4.51179 -2.353426 0.841968 
H -0.209836 -2.487927 -1.472032 
C 1.557625 -1.166544 0.228968 
C 1.269216 -2.338443 0.939968 
C 2.159845 -3.400754 0.958968 
C 3.367876 -3.314176 0.266968 
C 3.707285 -2.142294 -0.393032 
C 2.817657 -1.075983 -0.376032 
O 3.231069 0.104872 -0.961032 
C 2.741465 1.241043 -0.361032 
C 3.547861 2.374762 -0.342032 
H 4.511853 2.353426 -0.842032 
N 3.194251 3.491886 0.282968 
C 2.02225 3.491295 0.931968 
C 1.146876 2.4176 0.935968 
C 1.47847 1.255484 0.233968 
H 0.2099 2.487927 1.471968 
H 1.773568 4.400381 1.469968 
H 4.659326 -2.024626 -0.894032 
H 4.059585 -4.147417 0.269968 
H 1.913532 -4.297668 1.511968 
H 0.334189 -2.415117 1.477968 
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Z-anti-folded 
 
 
C 0.30474 -0.608049 -0.009991 
C -0.30474 0.608049 -0.009991 
C -0.666343 1.387102 1.200791 
C -1.262112 0.86654 2.356621 
C -1.538357 1.678733 3.445189 
C -1.227035 3.03797 3.403027 
C -0.691861 3.591469 2.249822 
C -0.45027 2.769827 1.156153 
O -0.003928 3.371732 -0.004035 
C -0.436 2.769447 -1.161811 
C -0.681925 3.574853 -2.269851 
H -0.476701 4.639128 -2.212912 
N -1.179234 3.094747 -3.404085 
C -1.46914 1.788336 -3.447762 
C -1.227035 0.912452 -2.401312 
C -0.647286 1.390476 -1.221988 
H -1.481085 -0.132973 -2.505772 
H -1.913897 1.426641 -4.368648 
H -0.485528 4.650852 2.167745 
H -1.430539 3.671046 4.257871 
H -1.995996 1.253363 4.329597 
H -1.501292 -0.187038 2.399682 
C 0.666343 -1.387102 1.200791 
C 1.262112 -0.86654 2.356621 
C 1.538357 -1.678733 3.445189 
C 1.227035 -3.03797 3.403027 
C 0.691861 -3.591469 2.249822 
C 0.45027 -2.769827 1.156153 
O 0.003928 -3.371732 -0.004035 
C 0.436 -2.769447 -1.161811 
C 0.681925 -3.574853 -2.269851 
H 0.476701 -4.639128 -2.212912 
N 1.179234 -3.094747 -3.404085 
C 1.46914 -1.788336 -3.447762 
C 1.227035 -0.912452 -2.401312 
C 0.647286 -1.390476 -1.221988 
H 1.481085 0.132973 -2.505772 
H 1.913897 -1.426641 -4.368648 
H 0.485528 -4.650852 2.167745 
H 1.430539 -3.671046 4.257871 
H 1.995996 -1.253363 4.329597 
H 1.501292 0.187038 2.399682 
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E-twisted 
C -2.750539 1.255288 -0.648216 
O -3.539608 0.182878 -0.335798 
C -2.991502 -0.860445 0.351834 
C -3.890551 -1.806409 0.836752 
C -3.427137 -2.854556 1.611231 
C -2.067661 -2.93246 1.927117 
H -1.704052 -3.719021 2.576292 
C -1.187437 -1.99143 1.430986 
C -1.608088 -0.951247 0.575888 
C -0.697738 0.085532 0.08723 
C 0.697737 -0.085544 0.08719 
C 1.361767 -1.282808 -0.440933 
C 2.75053 -1.255293 -0.648347 
C 3.41776 -2.32335 -1.249594 
H 4.495174 -2.260908 -1.368222 
N 2.803909 -3.411046 -1.687853 
C 1.469045 -3.440166 -1.55014 
C 0.73258 -2.433869 -0.959535 
H -0.339411 -2.541218 -0.910048 
H 0.966948 -4.318885 -1.940639 
O 3.539612 -0.182938 -0.335852 
C 2.991521 0.860395 0.351787 
C 1.608099 0.951221 0.575826 
C 1.187452 1.991465 1.430847 
C 2.06769 2.932503 1.92695 
C 3.427166 2.854559 1.611097 
C 3.890576 1.80637 0.836661 
H 4.941731 1.687465 0.6069 
H 4.12237 3.590861 1.994624 
H 1.704071 3.719106 2.576065 
H 0.143101 2.045149 1.706532 
C -1.361767 1.282805 -0.440815 
C -0.732558 2.433905 -0.959356 
C -1.469078 3.440199 -1.549979 
H -0.967015 4.318925 -1.940504 
N -2.803963 3.411055 -1.687709 
C -3.417803 2.323379 -1.249375 
H -4.495196 2.26087 -1.368084 
H 0.339431 2.541244 -0.909919 
H -0.143099 -2.045066 1.706716 
H -4.122372 -3.590857 1.994805 
H -4.941705 -1.687509 0.606984 
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Z-twisted 
 
C 2.89619 -1.059512 -0.508936 
O 3.586998 0.011612 -0.023936 
C 2.894809 1.066488 0.503064 
C 3.686627 2.07663 1.045064 
C 3.090435 3.150523 1.677064 
C 1.697427 3.192273 1.792064 
H 1.220282 4.003187 2.327064 
C 0.925607 2.188134 1.243064 
C 1.489801 1.107235 0.532064 
C 0.704003 -0.017906 0.012064 
C -0.703997 -0.018158 -0.011936 
C -1.490199 1.106701 -0.531936 
C -2.895191 1.065449 -0.502936 
C -3.687372 2.075306 -1.045936 
H -4.763356 1.982113 -0.968936 
C -3.091565 3.149413 -1.676936 
C -1.698573 3.191663 -1.791936 
C -0.926393 2.188802 -1.242936 
H 0.1456 2.227994 -1.367936 
H -1.220718 4.002749 -2.325936 
H -3.702706 3.936304 -2.101936 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O -3.587002 0.010324 0.023064 
C -2.89581 -1.060552 0.509064 
C -1.495796 -1.1363 0.501064 
C -0.978596 -2.253208 1.190064 
C -1.820425 -3.206359 1.724064 
N -3.160436 -3.143599 1.656064 
C -3.674628 -2.074691 1.069064 
H -4.755644 -1.983885 1.027064 
H -1.408271 -4.064285 2.245064 
H 0.087425 -2.370016 1.315064 
C 1.496204 -1.135763 -0.500936 
C 0.979404 -2.253856 -1.189936 
C 1.821575 -3.206705 -1.723936 
H 1.408729 -4.063779 -2.244936 
N 3.161564 -3.143465 -1.655936 
C 3.675372 -2.074372 -1.068936 
H 4.756356 -1.983178 -1.026936 
H -0.086575 -2.370047 -1.314936 
H -0.1464 2.227942 1.369064 
H 3.701294 3.937632 2.102064 
H 4.762644 1.983823 0.96906
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Table 2.1. DFT-B3LYP and M06 calculated energies of 1 (6-311+G(2d,p) basis set). 
 B3LYP E (Hartree) E (kcal/mol) Relative E (kcal/mol) 
E-anti-folded -1182.897 -742279.485 0.000 
Z-anti-folded -1182.896 -742279.311 0.174 
E-twisted -1182.888 -742274.130 5.355 
Z-twisted -1182.887 -742273.629 5.856 
 
 M06 E (Hartree) E (kcal/mol) Relative E (kcal/mol) 
E-anti-folded -1182.044 -741744.327 0.000 
Z-anti-folded -1182.044 -741744.274 0.053 
E-twisted -1182.034 -741738.193 6.134 
Z-twisted -1182.033 -741737.656 6.670 
 
 B3LYP ΔH (Hartree) ΔH (kcal/mol) Relative ΔH (kcal/mol) 
E-anti-folded -1182.896 -742278.893 0.000 
Z-anti-folded -1182.895 -742278.718 0.175 
E-twisted -1182.887 -742273.538 5.355 
Z-twisted -1182.886 -742273.037 5.856 
 
 M06 ΔH (Hartree) ΔH (kcal/mol) Relative ΔH (kcal/mol) 
E-anti-folded -1182.043 -741743.735 0.000 
Z-anti-folded -1182.043 -741743.681 0.053 
E-twisted -1182.033 -741737.601 6.134 
Z-twisted -1182.032 -741737.064 6.670 
 
 B3LYP ΔG (Hartree) ΔG (kcal/mol) Relative ΔG (kcal/mol) 
E-anti-folded -1182.963 -742321.288 0.000 
Z-anti-folded -1182.962 -742320.721 0.567 
E-twisted -1182.956 -742316.530 4.758 
Z-twisted -1182.955 -742316.386 4.903 
 
 M06 ΔG (Hartree) ΔG (kcal/mol) Relative ΔG (kcal/mol) 
E-anti-folded -1182.111 -741786.387 0.000 
Z-anti-folded -1182.110 -741785.890 0.497 
E-twisted -1182.102 -741780.574 5.813 
Z-twisted -1182.101 -741780.381 6.006 
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Table 2.2. Calculated excitation energies (nm) of 1 in chloroform (6-311+G(2d,p) basis set). 
  CIS ωB97XD M06 B3LYP PBEPBE LSDA 
E-anti-folded 292.20 344.13 391.30 395.40 455.51 459.30 
Z-anti-folded 292.43 344.46 392.43 396.64 457.23 461.66 
E-twisted 554.84 617.38 632.45 660.89 704.40 709.75 
Z-twisted 597.53 662.41 694.28 707.69 752.02 758.01 
 
 
 
Table 2.3. Calculated oscillator strength of the excited states of 1 in chloroform (6-311+G(2d,p) 
basis set). 
 
  CIS ωB97XD M06 B3LYP PBEPBE LSDA 
E-anti-folded 1.0456 0.5787 0.4590 0.4462 0.3496 0.3500 
Z-anti-folded 1.0150 0.5652 0.4435 0.4327 0.3415 0.3324 
E-twisted 0.6634 0.4068 0.3770 0.3615 0.3393 0.3279 
Z-twisted 0.6096 0.3712 0.3315 0.3263 0.3061 0.2968 
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Table 2.4.  Summary of Structure Determination of (E)-1. 
 
Empirical formula  C24H14N2O2 
Formula weight  362.37 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  tetragonal 
Space group  I41/a      
Cell constants:   
a  18.5111(12) Å 
c  9.7964(7) Å 
Volume 3356.8(4) Å3 
Z 8 
Density (calculated) 1.434 Mg/m3 
Absorption coefficient 0.093 mm-1 
F(000) 1504 
Crystal size 0.30 x 0.20 x 0.08 mm3 
Theta range for data collection 2.20 to 26.40° 
Index ranges -23 ≤ h ≤ 23, -23 ≤ k ≤ 17, -12 ≤ l ≤ 12 
Reflections collected 35582 
Independent reflections 1722 [R(int) = 0.0323] 
Completeness to theta = 26.40° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7454 and 0.6814 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1722 / 0 / 159 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0308, wR2 = 0.0760 
R indices (all data) R1 = 0.0358, wR2 = 0.0805 
Largest diff. peak and hole 0.163 and -0.137 e.Å-3 
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Figure 2.6. Differential Scanning Calorimetry for (E)-1/(Z)-1 
 
 
  
	  55	  
	  
 
 
 
Figure 2.7. HPLC analysis for (E)-6/(Z)-6 
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Figure 2.8. 1H NMR of (E)-1/(Z)-1 in acetone-d6, DMF-d7, and CDCl3. 
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Figure 2.9. 1H and 13C NMR of (E)-1/(Z)-1 in DMF-d7 and CF3CO2D. 
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Figure 2.10. 1H NMR of (E)-1/(Z)-1 in DMF-d7 at room temperature and 140 °C. 
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Figure 2.11. COSY and TOCSY of (E)-1/(Z)-1 in DMF-d7 at 140 °C. 
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Figure 2.12. HSQC and HMBC of (E)-1/(Z)-1 in DMF-d7 at 140 °C. 
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Figure 2.13.Variable-temperature 1H NMR of (E)-1/(Z)-1 in DMF-d7, decoupled at 3160 
Hz. 
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Figure 2.14. 1H and 13C NMR of 4 in CDCl3. 
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Figure 2.15. 1H and 13C NMR of 5 in CDCl3. 
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Figure 2.16. 1H and 13C NMR of (E)-6/(Z)-6 in D2O. 
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Chapter 3 : Synthesis and Properties of Lysosome-Specific Photoactivatable Probes 
for Live-Cell Imaging 
 
 
 
 
 
 
 
 
 
 
The content of this chapter was originally published in Chemical Science.  
This work was done in cooperation with Dr. Robert-André F. Rarig. 
Tran, M. N.; Rarig, R. F.; Chenoweth, D. M. Chem. Sci. 2015, 6, 4508-4512. 
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. 
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3.1 Introduction 
Fluorescence microscopy is a powerful tool that is universally employed to study 
biological processes at the cellular level.1-3 Many fluorescent dyes targeting a multitude 
of organelles and sub-cellular targets have been developed.4,5 Photoactivatable dyes are 
an important but rare class of probes allowing for spatial and temporal control during 
imaging studies.6-11 Photoactivatable dyes can be grouped into two broad categories, the 
first switching from a dark state to a fluorescent state and the second converting from one 
fluorescent state to another fluorescent state.12-14 The latter are often referred to as 
photoconvertible dyes. Each category has its own merit depending on the experimental 
conditions. Photoconvertible dyes have the added advantage of being able to track the 
pre-activated state, although few examples of useful dyes in this category currently 
exist.15,16 A combined Cy5-Cy3 probe was introduced by Johnsson et al. in 2010 as 
photoconvertible protein label.14 In 2013, cell tracking experiments were performed using 
a commercial membrane stain DiR.17 Herein, we report a new photoconvertible 
lysosomal dye based on a diazaxanthilidene scaffold. The fluorescent probe is water-
soluble, cell permeable, and noncytotoxic with a large Stokes shifts for both the pre- and 
post-activated forms. 
In previous studies we reconciled a proposal assigning the molecular structure of 
the natural product xylopyridine A as diazaxanthilidene (E)-1.18 During our discovery 
that (E)-1 was not consistent with the structure of the natural product, we made several 
important observations about the photophysical and photochemical properties of (E)-
1/(Z)-1.18 We discovered that methylation of the pyridine ring led to water-soluble 
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derivatives, facilitating biological experiments. In this report, we show that a simple 
change in solvent produces two different derivatives, both of which can be used as 
lysosomal fluorescent probes for live cell imaging experiments. Importantly, we show 
that the monomethylated derivative can be photoactivated in cells, allowing for spatial 
and temporal control during the imaging process. Additionally, these new fluorescent 
probes are cell permeable and noncytotoxic with good photostability and large Stokes 
shifts, facilitating applications in biological imaging experiments. 
3.2 Results and Discussion 
We developed an efficient 5 step synthesis of (E)-1/(Z)-1 resulting in a 41% 
overall yield.18 Treatment of the (E)-1/(Z)-1 with an excess of dimethyl sulfate in 
chloroform provided dimethylated derivatives (E)-2/(Z)-2 in 64% yield, while one 
equivalent of dimethyl sulfate in toluene gave rise to the monomethylated derivatives 
(E)-3/(Z)-3 in 55% yield (Scheme 3.1). Both methylated forms are isolated as a mixture 
of equilibrating E and Z isomers. 
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Scheme 3.1. Synthesis of (E)-2/(Z)-2 and (E)-3/(Z)-3. 
 
 
Similar to (E)-1/(Z)-1, the methylated products were fluorescent with large 
bathochromic shifts observed in both absorption (46 nm and 32 nm) and emission (83 nm 
and 101 nm) spectra. Both (E)-2/(Z)-2 and (E)-3/(Z)-3 were soluble in water and 
exhibited large Stokes shifts of 94 nm and 126 nm, respectively (Figure 3.1). 
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Figure 3.1. Absorption and emission spectra of (E)-1/(Z)-1, (E)-2/(Z)-2, and (E)-3/(Z)-3. (A) 
Absorption spectra of (E)-1/(Z)-1, (E)-2/(Z)-2, and (E)-3/(Z)-3 (λmax = 378 nm, 424 nm, and 410 
nm, respectively). (B) Emission spectra of (E)-1/(Z)-1, (E)-2/(Z)-2, and (E)-3/(Z)-3 (λmax = 435 
nm, 518 nm, and 536 nm, respectively). Spectra of (E)-1/(Z)-1 were recorded in chloroform, 
while spectra of (E)-2/(Z)-2, and (E)-3/(Z)-3 were recorded in water.  
 
Live cell imaging studies were performed using (E)-2/(Z)-2 and (E)-3/(Z)-3. Both 
compounds are water-soluble and can be dosed in water or buffer without the addition of 
organic solvents, which can be problematic for live cell imaging. After a 3-hour 
incubation in a humidified atmosphere with 5% CO2 at 37 °C, both dyes were found to be 
cell permeable, exhibiting punctuate staining patterns in HeLa cells, consistent with 
lysosomes (Figure 3.2). Unlike (E)-2/(Z)-2, (E)-3/(Z)-3 was found to be 
photoconvertible, a property that allowed for sequential labelling of individual cells 
(Figure 3.5, 3.6).  
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To confirm lysosomal staining of (E)-3/(Z)-3, co-staining experiments with 
LysoTracker Red DND-99 were performed and the punctate localization patterns of (E)-
3/(Z)-3 were consistent with lysosome localization (Figure 3.3a). Control experiments 
with (E)-3/(Z)-3 alone and LysoTracker alone were also performed. Images of each 
sample were kept at the same brightness and contrast. Almost no bleed-through was 
observed. Compared to LysoTracker Red DND-99,19 (E)-3/(Z)-3 exhibited similarly low 
cytotoxicity (Figure 3.3c) and higher photostability. Only a 20% decrease in intensity of 
(E)-3/(Z)-3 was observed after 30 seconds of continuous irradiation, as opposed to 40% 
in LysoTracker (Figure 3.3b). Imaging and photobleaching studies were carried out using 
identical conditions, a 405 nm laser excitation for (E)-3/(Z)-3 and a 594 nm laser 
excitation for LysoTracker. 
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Figure 3.2. Differential interference contrast (DIC), fluorescence, and overlay images of HeLa 
cells stained with (E)-2/(Z)-2 and (E)-3/(Z)-3 with Hoechst 33342. The cells were first incubated 
with (E)-2/(Z)-2 and (E)-3/(Z)-3, which were observed using a 405/700 channel. Hoechst 33342 
was then added and imaged after 10 minutes using a 405/430 channel. Scale bar = 10 µm. 
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Figure 3.3a. DIC and fluorescence images of HeLa cells incubated with (E)-3/(Z)-3 and 
LysoTracker. A 405/525 channel and a 552/625 channel were used to observed (E)-3/(Z)-3 and 
Lysotracker, respectively. Scale bar = 10 µm. 
 
 
 
Figure 3.3b. Timelapse experiments of (E)-3/(Z)-3 and LysoTracker. Normalized fluorescence 
intensity of (E)-3/(Z)-3 and LysoTracker over 30 seconds of irradiation (100 laser pulses of 300 
ms). A 444/495 channel and a 594/632 channel were used to for (E)-3/(Z)-3 and LysoTracker, 
respectively. Each set of data were fitted to a one phase exponential curve. The rate constant and 
half-life were 0.22 s-1 and 3.15 s for (E)-3/(Z)-3 and 0.07 s-1 and 9.75 s for LysoTracker. 
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Figure 3.3c. Cell viability experiments of (E)-3/(Z)-3 and LysoTracker. HeLa cells incubated 
with (E)-3/(Z)-3 and LysoTracker over 24 and 48 hours at 37 °C in a humidified atmosphere with 
5% CO2. 
 
To study the photoreaction of (E)-3/(Z)-3, a solution of (E)-3/(Z)-3 in water was 
irradiated with visible light (a 26W fluorescent light bulb) for 24 hours (Scheme 3.2). 
Photoproduct 4 was isolated in 64% yield. The photoproduct 4 showed a bathochromic 
shift of 89 nm and a large Stokes shift (98 nm) for the photoproduct (Figure 3.4). 
Photoactivation experiments were performed in live HeLa cells incubated with (E)-3/(Z)-
3. The pre-activated (E)-3/(Z)-3 can be observed using a 405 nm excitation wavelength 
and a 525 (±25) nm emission wavelength. The post-activated species can be excited at 
488 nm and observed at 675 (±25) nm emission. Alternating 2.5-second pulses with a 488 
nm and a 405 nm laser were used to investigate the photoconversion of (E)-3/(Z)-3. The 
photoproduct signal quickly increased, approaching its maximum at 180 seconds 
followed by a slow decrease to 80% after 400 seconds. The emission signal of the pre-
activated state is reduced slowly followed by a plateau around 200 seconds at 60% of the 
original brightness (Figure 3.5). The sharp increase in fluorescence signal of the post-
activated form but slow decrease in fluorescence signal of the pre-activated form is a 
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result of the relative brightness of the photoproduct compared to (E)-3/(Z)-3. Only 40% 
of (E)-3/(Z)-3 was photoconverted but the increase in brightness of the photoproduct still 
allows for good signal detection over background. The remaining 60% of (E)-3/(Z)-3 
serves as a reference. This feature allows the ability to image both pre- and post-activated 
regions during imaging studies using two different fluorescent states as compared to 
traditional photoactivatable dyes with a pre-activated dark state and a post-activated 
fluorescent state. Similar experiments using a 444 nm laser instead of a 405 nm laser for 
(E)-3/(Z)-3 excitation also showed photoactivation. 
 
Scheme 3.2. Photoreaction of (E)-3/(Z)-3. 
 
	  
 
Figure 3.4. Absorption and emission spectra (E)-3/(Z)-3 of and 4. Photoproduct 4 absorption λmax 
= 499 nm, emission λmax = 597 nm). 
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Figure 3.5a. Timelapse experiment of (E)-3/(Z)-3. DIC and fluorescence images of HeLa cells 
stained with (E)-3/(Z)-3 and observed at 405/525 and 488/675 over 80 alternating 2.5-second 
pulses in a total of 200 seconds. Scale bar = 10 µm. 
 
 
 
Figure 3.5b. Normalized fluorescence intensity of the two channels 405/525 and 488/675 over 
400 seconds of irradiation. Each data set were fitted to a one phase exponential curve. The rate 
constants and half-lives are 0.011 s-1 and 63.6 s for the 405/525 channel and 0.026 s-1 and 26.7 s 
for the 488/675 channel. 
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Figure 3.6. Sequential activation experiment of (E)-3/(Z)-3. Five cells (cell 1, 2, 3, 4, and 5) in a 
field of ten HeLa cells were activated individually. Dashed lines showed the cell periphery 
determined by DIC image. Each cell was activated by a 40-second irradiation using a 405 nm 
laser. The excitation and emission wavelength for imaging are 488 nm and 675 (±25) nm, 
respectively. Scale bar = 10 µm. 
 
To investigate spatial selectivity, sequential activation was carried out with a 
dense population of HeLa cells. A 405 nm laser was used for photoconversion and a 
488/675 channel was used to observe the post-activated state. Five individual cells (cell 
1, 2, 3, 4, and 5) can be sequentially activated by a 40-seconds of irradiation using a 405 
nm laser (Figure 3.6). 
	  77	  
	  
3.3 Conclusions 
In conclusion, a new class of water-soluble dixanthilidene fluorescent probe has 
been synthesized and used for lysosomal imaging in live cells. The monomethylated 
derivative can be photoconverted to a new fluorescent state, allowing precise 
spatiotemporal control during imaging experiments. These new fluorescent probes are 
cell permeable and photostable displaying large Stokes shifts and low cytotoxicity. 
3.4 Material and Methods 
General information: 
All reagents were purchased either from Sigma Aldrich or Acros Organics and 
used without any further purification. Anhydrous solvents were purchased from Fisher 
Scientific and passed through an alumina column of a solvent purification system. 
Column chromatography was performed using 230-400 mesh silica gel from Silicycle. 
Reversed phase column chromatography was carried out using a CombiFlash Rf System 
with a RediSep Rf Gold C18 column from Teledyne ISCO. High performance liquid 
chromatography (HPLC) was performed using a Phenomenex column (Luna 5u C18(2) 
100A; 250 x 4.60 mm, 5 micron) on a Jasco HPLC system. 1H-NMR and 13C-NMR data 
were collected on a Bruker DMX 500 (500 MHz). High resolution mass spectrometry 
was performed by Dr. Rakesh Kohli at the Mass Spectrometry Facility of the Department 
of Chemistry, University of Pennsylvania using a Waters LCT Premier XE Mass 
Spectrometer (model KE 332). UV-Vis absorption spectra were recorded in a semi-micro 
	  78	  
	  
1-cm-pathlength quartz cuvette purchased from Starna Cells on a Jasco V-650 
spectrophotometer. Fluorescence emission spectra were obtained using a micro square 1-
cm-pathlength quartz fluorimeter cuvette from Starna Cells on a Horiba Jobin-Yvon 
FluoroLog. 
 
Synthesis:  
	  
A mixture of (E)-1/(Z)-1 (264 mg, 0.73 mmol) was dissolved in 15 mL 
chloroform. Dimethylsulfate (0.1 mL, 1.05 mmol) was added. The reaction mixture was 
heated under reflux for 24 hours. The reaction was allowed to cool down to room 
temperature before 50 mL water was added. The mixture was transferred to a separatory 
funnel to remove the organic layer. The aqueous layer was washed twice with 15 mL 
chloroform. Water was removed under vacuum and the residue was purified by reversed 
phase column chromatography using water containing 0.1% (v/v) trifluoroacetic acid and 
acetonitrile as eluents. (E)-1/(Z)-1 was obtained as an orange solid (279 mg, 0.45 mmol, 
62%). 1H NMR (500 MHz, CDCl3): δ (ppm) 9.06 (0.6, s), 9.01 (2.0, s), 8.40 (0.6, d, J = 
6.0 Hz), 8.32 (2.0, d, J = 6.5 Hz), 7.83 (2.6, overlapping doublet), 7.56 (4.0, m), 7.50 
(1.2, m), 7.28 (0.6, d, J = 8.0 Hz), 7.23 (2.0, d, J = 7.5 Hz), 7.16 (2.0, m), 7.11 (0.6, m), 
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4.42 (1.8, s), 4.40 (6.0, s).  13C NMR (126.9 MHz, CDCl3): δ (ppm) 163.0, 162.7, 144.3, 
153.3, 139.5, 139.4, 139.1, 136.9, 136.5, 131.8, 131.4, 127.8, 127.5, 125.3, 125.2, 125.1, 
124.8, 122.8, 120.2, 119.6, 118.1, 117.6, 117.5, 115.2, 48.2, 48.1. HRMS (m/z): [M]2+ 
calcd for C26H20N2O22+, 392.1516; found, 392.1536. Extinction coefficient ε = 11051 M-
1cm-1 (solvent: water). Quantum yield Φ = 0.176 (solvent: water, standard: 9,10-
diphenylanthracene in cyclohexane). 
 
 
A mixture of (E)-1/(Z)-1 (41 mg, 0.11 mmol) was suspended in 20 mL toluene. A 
1% solution of dimethylsulfate (0.53 mL, 0.06 mmol) was added. The reaction mixture 
was heated under reflux for 12 hours. Another batch of dimethylsulfate (1% solution in 
toluene, 0.53 mL) was added. The reaction mixture was heated under reflux for an 
additional 24 hours before cooled down to room temperature. The precipitate was filtered 
and washed with toluene, dissolved in water and purified by reversed phase column 
chromatography using 0.1% TFA/water and acetonitrile as eluents. The product is a 
yellow solid (30 mg, 55%). Characterization data can be found in our previous study.18 
Extinction coefficient ε = 9867 M-1cm-1 (solvent: water). Quantum yield Φ = 0.051 
(solvent: water, standard: 9,10-diphenylanthracene in cyclohexane).20 
	  80	  
	  
 
 
A mixture of (E)-3/(Z)-318 (17.2 mg, 0.035 mmol) was dissolved in 20 mL water. 
The reaction mixture was stirred and irradiated with a 26W fluorescent light bulb for 3 
days. Water was removed under vacuum and the residue was purified by reversed phase 
column chromatography using 0.1% TFA/water and acetonitrile as eluents. Photoproduct 
4 was obtained as a red solid (10.9 mg, 0.023 mmol, 64%). 1H NMR (500 MHz, CDCl3): 
δ (ppm) 8.57 (1.0, s), 8.27 (1.0, s), 8.10 (1.0, d, J = 6.5 Hz), 7.93 (1.0, d, J = 5.5 Hz), 7.68 
(1.0, d, J = 6.5 Hz), 7.51 (1.0, d, J = 8.0 Hz), 7.45 (1.0, d, J = 8.0 Hz), 7.38 (1.0, t, J = 8.0 
Hz), 7.33 (1.0, t, J = 8.0 Hz), 7.25 (1.0, d, J = 5.5 Hz), 7.01 (1.0, d, J = 8.0 Hz), 6.87 (1.0, 
d, J = 8.0 Hz), 4.29 (3.0, s).  13C NMR (126.9 MHz, CDCl3): δ (ppm) 162.9, 162.6, 150.2, 
148.7, 147.5, 147.2, 138.8, 135.8, 130.5, 130.0, 128.3, 122.8, 120.7, 118.2, 117.9, 117.7, 
117.5, 115.2, 114.3, 113.6, 113.4, 47.8. HRMS (m/z): [M]+ calcd for C25H15N2O2+, 
375.1134; found, 375.1139. Extinction coefficient ε = 10437 M-1cm-1 (solvent: water). 
Quantum yield Φ = 0.101 (solvent: water, standard: fluorescein in 0.1N NaOH). 
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Cell imaging 
HeLa cells were cultured in a 60 mm culture dish using Dulbecco's Modified 
Eagle Medium (DMEM) media with phenol red, 10 % Fetal Bovine Serum and 1% 
penicillin-streptomycin purchased from Life Technologies at 37 oC under a humidified 
atmosphere with 5% CO2. At least one day before imaging, the cells were detached using 
0.25% trypsin-EDTA and transferred to a MatTek 35 mm glass bottom poly-D-lysine 
coated dish and incubated in 2 mL of the above mentioned media at 37 °C under a 
humidified atmosphere with 5% CO2. Before imaging, cells were incubated with (E)-
2/(Z)-2 (5 mM stock solution in water, 5 µM final concentration, 3 to 12 hours), (E)-
3/(Z)-3 (5 mM stock solution in water, 5 µM final concentration, 3 to 12 hours), or 
LysoTracker Red DND-991 (1 mM stock solution in DMSO, 1 µM final concentration, 1 
hour) at 37 °C. Excess dyes were removed by washing twice with non-phenol red DMEM 
before imaging. Cells were kept in 1 mL non-phenol red DMEM during imaging. Images 
were obtained from either Leica DM4000 spinning disk confocal microscope equipped 
with a 100x/1.4 NA oil immersion objective (for cell imaging experiments on Figure 
S12), or a Leica TCS SP8 confocal microscope equipped with a 63x/1.4 NA oil 
immersion objective lens (for other cell imaging experiments). Excitation and emission 
wavelengths for each sample were included in figures or figure captions. 
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Cytotoxicity studies 
Cytotoxicity studies were performed in a 96-well plate. HeLa cells were detached 
from cell culture dish using 0.25% trypsin-EDTA and transfer to a falcon tube. Cell 
concentration was determined using a hemocytometer with Trypan Blue stain to exclude 
dead cells. Cell suspension was then diluted to 100,000 cells/mL and loaded to wells (50 
µL/well). After 24 hours, (E)-3/(Z)-3 in water (5 µM final concentration), LysoTracker 
Red DND-99 in DMSO (1 µM final concentration), and DMSO (vehicle control for 
LysoTracker, 1 µM final concentration) were added and the plate was incubated at 37 °C 
under a humidified atmosphere with 5% CO2. The final volume was 100 µL/well. After 
22 hours and 46 hours, Alamar Blue (10 µL) was added to each well and the plate was 
incubated at the above-mentioned condition for 2 hours. Cell viability was checked using 
fluorescence intensity (560 nm excitation and 590 nm emission) on a Tecan M1000 plate 
reader. 
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3.7 Spectra and supplemental information 
 
Figure 3.7. Absorption and emission spectra of (E)-1/(Z)-1, (E)-2/(Z)-2, (E)-3/(Z)-3, and 4 in (A) 
chloroform, (B) ethanol, (C) dimethylsulfoxide, and (D) water. 
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Figure 3.8. Absorption and emission spectra of (A) (E)-1/(Z)-1, (B) (E)-2/(Z)-2, (C) (E)-3/(Z)-3, 
and (D) 4 in chloroform, ethanol, dimethylsulfoxide, and water. (E) Summary of λmax 
absorption/λmax emission of (E)-1/(Z)-1, (E)-2/(Z)-2, (E)-3/(Z)-3, and 4 in different solvents. 
Absorption and emission spectra of (E)-1/(Z)-1 in water could not be recorded because of low 
solubility. 
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Figure 3.9. Costaining experiments of (E)-3/(Z)-3 and LysoTracker. DIC and fluorescence 
images of HeLa cells incubated with (E)-3/(Z)-3 and LysoTracker (top panel), (E)-3/(Z)-3 only 
(middle panel), and LysoTracker only (bottom panel). A 405/525 channel and a 552/625 channel 
are used to observed (E)-3/(Z)-3 and Lysotracker, respectively. All images of each sample were 
kept at the same brightness and contrast. Almost no bleed-through was observed. Scale bar = 10 
µm.  
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Figure 3.10. Timelapse experiment of (E)-3/(Z)-3. (A) DIC and fluorescence images of HeLa 
cells stained with (E)-3/(Z)-3 and observed at 405/525 and 488/675 over 80 alternating 2.5-
second pulses in a total of 200 seconds. Scale bar = 10 µm. (B) Normalized fluorescence intensity 
of the two channels 405/525 and 488/675 over 400 seconds of irradiation. 
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Figure 3.11. Timelapse experiment of (E)-3/(Z)-3. (A) DIC and fluorescence images of HeLa 
cells stained with (E)-3/(Z)-3 and observed at 444/525 and 488/585 over 1200 alternating 200-
milisecond pulses in a total of 240 seconds. Scale bar = 10 µm. (B) Normalized fluorescence 
intensity of the two channels 444/525 and 488/585 over 240 seconds of irradiation.  
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Sequential	  activation	  experiments	  of	  (E)-­‐3/(Z)-­‐3	  (enlarged	  from	  Figure	  3.6a)	  
	  
 
Figure 3.12. Differential interference contrast (DIC) of HeLa cells stained with (E)-3/(Z)-3. 
Scale bar = 10 µm.(Enlarged from figure 3.6a) 
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Figure 3.13.  Fluorescent image of HeLa cells stained with (E)-3/(Z)-3. Cell 1 was selectively 
activated. Scale bar = 10 µm. (Enlarged from figure 3.6a) 
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Figure 3.14.  Fluorescent image of HeLa cells stained with (E)-3/(Z)-3. Cell 1 and 2 were 
selectively activated. Scale bar = 10 µm. (Enlarged from figure 3.6a) 
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Figure 3.15. Fluorescent image of HeLa cells stained with (E)-3/(Z)-3. Cell 1, 2 and 3 were 
selectively activated. Scale bar = 10 µm. (Enlarged from figure 3.6a) 
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Figure 3.16. Fluorescent image of HeLa cells stained with (E)-3/(Z)-3. Cell 1, 2, 3, and 4 were 
selectively activated. Scale bar = 10 µm. (Enlarged from figure 3.6a) 
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Figure 3.17. Fluorescent image of HeLa cells stained with (E)-3/(Z)-3. Cell 1, 2, 3, 4, and 5 were 
selectively activated. Scale bar = 10 µm. (Enlarged from figure 3.6a) 
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Figure 3.18. Sequential activation of (E)-3/(Z)-3. Four cells (cell 1, 2, 3, and 4) in a field of 
fifteen HeLa cells were activated individually. Dashed lines showed the cell periphery determined 
by DIC image. Each cell was activated by a 40-second irradiation using a 405 nm laser. Pre-
activated signal was shown in green, observed by a 405/525 channel. Post-activated signal was 
shown in orange, observed by a 488/675 channel. Scale bar = 10 µm. 
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Figure 3.19. HPLC chromatogram of (E)-2/(Z)-2. Water containing 0.1% (v/v) trifluoroacetic 
acid and acetonitrile were used as eluents. Flow rate was 1 mL/min. Method time was 20 minutes. 
Time 
(min) 
% 
acetonitrile 
Time 
(min) 
% 
acetonitrile 
0.00 0.0 15.00 100.0 
1.00 0.0 17.80 100.0 
13.00 50.0 18.00 0.0 
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Figure 3.20. HPLC chromatogram of 4. Water containing 0.1% (v/v) trifluoroacetic acid and 
acetonitrile were used as eluents. Flow rate was 1 mL/min. Method time was 24 minutes. 
Time 
(min) 
% 
acetonitrile 
Time 
(min) 
% 
acetonitrile 
0.00 30.0 15.50 100.0 
1.00 30.0 18.80 100.0 
15.00 80.0 19.00 30.0 
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Figure 3.21. HPLC chromatogram of an aqueous solution of (E)-2/(Z)-2 after 2 months at room 
temperature away from light. Water containing 0.1% (v/v) trifluoroacetic acid and acetonitrile 
were used as eluents. Flow rate was 1 mL/min. Method time was 20 minutes. 
Time 
(min) 
% 
acetonitrile 
Time 
(min) 
% 
acetonitrile 
0.00 0.0 15.00 100.0 
1.00 0.0 17.80 100.0 
13.00 50.0 18.00 0.0 
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Figure 3.22. HPLC chromatogram of a 1 mM aqueous solution of (E)-3/(Z)-3 after 2 months at 
room temperature away from light. Water containing 0.1% (v/v) trifluoroacetic acid and 
acetonitrile were used as eluents. Flow rate was 1 mL/min. Method time was 24 minutes. 
Time 
(min) 
% 
acetonitrile 
Time 
(min) 
% 
acetonitrile 
0.00 30.0 15.50 100.0 
1.00 30.0 18.80 100.0 
15.00 80.0 19.00 30.0 
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Figure 3.23. Mass spectrum of (E)-2/(Z)-2. 
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Figure 3.24. Mass spectrum of 4. 
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Figure 3.25. 1H and 13C NMR of (E)-2/(Z)-2 in D2O. 
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Figure 3.26. 1H and 13C NMR of 4 in D2O.  
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Chapter 4 : 2,2'-Diazaxanthylidene: a bis-tricyclic heteroaromatic ene scaffold for 
bioimaging fluorophores 
 
 
 
 
 
 
 
 
 
 
 
The content of this chapter has been submitted to for publication in Chemical Science.  
This work was done in cooperation with Dr. Robert-André F. Rarig and Sung-Eun Suh.	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4.1 Introduction 
Fluorescence microscopy is one of the most powerful tools to study biological 
activities.1-6 Fluorescent dyes allow visualization, tracking and monitoring of changes in 
locations and morphologies of different cellular organelles.7-9 To facilitate such 
investigation, prolonged exposure to excitation light is sometimes unavoidable, which 
can result in significant signal loss.10-13 Anti-fading agents have been developed to reduce 
bleaching. However, most are still fluorophore-dependent and primarily used for fixed 
specimens.1, 10, 14, 15 As a result, photostability has become one of the most important 
properties of live-cell imaging dyes.  
In previous report, we synthesized the reported structure of the natural product 
xylopyridine A and proposed a possible misassignment due to the significant discrepancy 
between characterization data.16 Despite that unexpected result, the obtained 
diazaxanthilidene scaffold still holds much interest owing to its fascinating potential for 
structure-specific nucleic acid binders16 and photoactivatable cellular fluorophores.17, 18 
Herein, we report new diazaxanthilidene derivatives as highly fluorescent 
photocyclization-oxidation derivatives with good biocompatibility, cell-permeablility, 
and photostability.  
4.2 Results and Discussion 
Upon exposure to 365 nm light from a Rayonet photoreactor with the addition of 
iodine and methyloxirane, a mixture of (E)-1/(Z)-116 underwent photocyclization-
oxidation to give a 3:7 mixture of the two photoproducts 2 and 3 in 74% yield (Figure 
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4.1).  Neither of the dihydrophenanthrene intermediates I-(E)-1 nor I-(Z)-1 was isolable 
from the reaction mixture. No coupling between the two adjacent pyridine rings in (Z)-1 
was observed.  
 
Figure 4.1. Photocyclization-oxidation reaction of (E)-1/(Z)-1 and crystal structures of (E)-1 and 
3. 
 
Photocyclization of (E)-1/(Z)-1 was facilitated by the anti-folded conformation, 
which aligned the reactive moieties nicely for a constructive in-phase interaction of the 
HOMO* (Figure 4.2). Therefore, the electrocyclization was photochemically allowed,19, 
20 giving the dihydrophenathrene intermediates, which were subsequently air oxidized to 
restore aromaticity. Photoproduct 2 originated from (Z)-1 while 3 was the product of (E)-
1 (Figure 4.1). 
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Figure 4.2. Calculated structure and molecular orbitals of (E)-1. (a) Optimized structure of (E)-1. 
16 (b) Calculated HOMO of (E)-1. Out-of-phase interaction leads to thermally disallowed 
electrocyclization. (c) Calculated HOMO* of (E)-1. In-phase interaction leads to photochemically 
allowed electrocyclization. Calculations were carried out using Gaussian 0921 with DFT-B3LYP 
method and 6-311+G(2d,p) basis set. 
 
X-ray crystallography was used to confirm the structure of 3 (Figure 4.1). 
Comparing the crystal structures of 1 and 3, it is suggested that the bathochromic shifts of 
76 nm in absorption and 39 nm in emission spectra of 3 (Figure 4.3) are the result of 
increased planarity within the scaffold, allowing for greater electron delocalization 
through the extended π-system. Similar bathochromic shifts were also observed in 2. The 
higher rigidity also reduces nonradiative bond rotation and improves quantum yield 
remarkably (Figure 4.3). Both photoproducts have higher quantum yields than most of 
the well-known fluorophores such as quinine, DAPI, Hoechst, Cy3, and Cy5.22, 23 
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Figure 4.3. Photoreaction of (E)-1/(Z)-1 and photophysical data of the photoproducts. (a) 
Photoreaction of (E)-1/(Z)-1. (b) Absorption spectra of (E)-1/(Z)-1, 2, and 3 in chloroform. (c) 
Absorption spectra of (E)-1/(Z)-1, 2, and 3 in chloroform. Inset: Chloroform solution of (E)-
1/(Z)-1, 2, and 3 under handheld 365 nm UV lamp. (d) Summary of photophysical properties of 
(E)-1/(Z)-1, 2, and 3. 
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Using confocal microscopy, both 2 and 3 were shown to be cell-permeable and 
localized primarily in tubular networks in the cytoplasm of live HeLa cells, as presented 
in co-staining experiments with Hoechst 33342,24 a commercially available nuclear stain 
(Figure 4.4a,b). Two channels, 444/495 and DAPI, were used to observe the 
photoproducts (2 and 3) and Hoechst 33342, respectively. For 2 and 3, high fluorescent 
contrast was still obtained even without washing out excess dye prior to imaging. 
Staining patterns remained the same with paraformaldehyde-fixed cells.  
To investigate the photostability of 2 and 3, timelapse microscopy experiments 
using a 444/495 channel were carried out. After 100 scans (300 ms/scan), only a slight 
decrease in intensity (10 to 20%) was detected with both 2 and 3, indicating high 
resistance to photobleaching (Figure 4.4c). In comparison, a similar experiment was 
performed using a 594/632 channel to observe MitoTracker Red FM,24 a commonly used 
commercially available mitochondrial stain. The dye was quite stable, but only about 
60% intensity remained at the end of the experiment. Cell viability assays in HeLa cells 
confirmed that both 2 and 3 had very low cytotoxicity (Figure 4.4d). 
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Figure 4.4a. DIC and fluorescence images of live HeLa cells stained with 2 and Hoechst 33342. 
A 444/495 channel was used to observed both compound 2 while a DAPI channel was used for 
Hoechst 33342. White dashed lines indicated cell boundaries. Scale bar = 10 µm.  
 
 
Figure 4.4b. DIC and fluorescence images of live HeLa cells stained with 3 and Hoechst 33342. 
A 444/495 channel was used to observed both compound 3 while a DAPI channel was used for 
Hoechst 33342. White dashed lines indicated cell boundaries. Scale bar = 10 µm 
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Figure 4.4c. Timelapse experiments of 2, 3, and MitoTracker Red FM. The average fluorescence 
intensity of 2, 3, and Mitotracker Red FM over 100 laser pulses of 300 ms were normalized to the 
starting value of each data set. A 444/525 channel was used to observe 2 and 3, while a 594/632 
channel was used for MitoTracker Red FM. 
 
 
Figure 4.4d. Viability assays of HeLa cells incubated with 2, 3, and MitoTracker Red FM. 
 
Methylation of one or both of the pyridine nitrogens in 2 and 3 gave rise to water-
soluble derivatives 4, 5, 6, 7, and 8 (Figure 4.5a). Even though quantum yields were 
decreased, all methylated products gained more than 40 nm bathochromic shift in 
absorption and 90 nm in emission spectra, resulting in much larger Stokes shifts (80-100 
nm) (Figure 4.5b,c). All absorption and emission wavelengths of the methylated 
photoproducts fell into the same range in the visible light spectrum with the dimethylated 
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compounds slightly more red-shifted than the corresponding monomethylated 
derivatives. Water solubility was also a benefit for biological applications.  
Live cell imaging experiments were performed using HeLa cells. All methylated 
products were cell-permeable and primarily localized in the nuclei, except for 8, which 
accumulated in vesicles within the cytoplasm. (Figure 4.6,7,8,9). In paraformaldehyde-
treated and ethanol-treated cells, all methylated photoproducts became much more 
selective nuclear stains. Similar localization patterns were also seen in neuro-2a, a mouse 
neuroblastoma cell line.  To assess the photostability of 4, 5, 6/7, and 8, timelapse 
experiments were performed with a 488/600 channel for the monomethylated derivatives 
4 and 6/7, and a 552/600 channel for the dimethylated derivatives 5 and 8. After 200 
seconds of continuous irradiation, around 80% or more of the average fluorescence 
intensity still remained, indicating high resistance to photobleaching (Figure 4.10). 
Viability assays showed low cytotoxicity for most methylated derivatives with more than 
80% viability after 48 hours. Compound 8 had the lowest viability, but more than 60% of 
the cells still survived after 48 hours (Figure 4.11). 
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Figure 4.5. Methylation reactions of 2 and 3 and photophysical data of the products. (a) 
Methylation reactions of 2 and 3. (b) Absorption and emission spectra of 2, 4 (Abs λmax = 499 
nm, Em λmax = 592 nm), and 5 (Abs λmax = 521 nm, Em λmax = 602 nm) in water. (c) Absorption 
and emission spectra of 3, 6/7 (Abs λmax = 493 nm, Em λmax = 572 nm), and 8 (Abs λmax = 498 
nm, Em λmax = 582 nm) in water. 
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Figure 4.6. Confocal microscopy images of live HeLa cells incubated with 4. The fluorescence 
image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure 4.7. Confocal microscopy images of live HeLa cells incubated with 5. The fluorescence 
image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure 4.8. Confocal microscopy images of live HeLa cells incubated with 6/7. The fluorescence 
image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure 4.9. Confocal microscopy images of live HeLa cells incubated with 8. The fluorescence 
image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure 4.10. Timelapse experiments of 4, 5, 6/7, and 8. The average fluorescence intensity over 
200 seconds of continuous irradiation were normalized to the starting value of each data set. The 
488/600 channel was used to observe 4 and 6/7, while 552/600 channel was used for 5 and 8. (d) 
Viabililty assays of HeLa cells incubated with 4, 5, 6/7, and 8 at 37 °C in a humidified 
atmosphere with 5% CO2 over 24 and 48 hours.  
	  
 
Figure 4.11. Viabililty assays of HeLa cells incubated with 4, 5, 6/7, and 8.  
 
4.3 Conclusions 
In conclusion, it has been demonstrated that photocyclization-oxidation of 2,2’-
diazaxanthylidene (E)-1/(Z)-1 provides two isomeric fluorophores that are 
bathochromatically shifted, biocompatible, cell-permeable, photostable, with high 
quantum yields and are well-suited as fluorescent stains for live cell imaging. 
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Methylation of these two photoproducts provide more red-shifted and equally photostable 
fluorescent cellular stains with the added advantages of larger Stokes shifts and increased 
water solubility.  
4.4 Material and Methods 
General information: 
Reagents for synthesis were purchased from Sigma Aldrich or Acros and used 
without further purification. Solvents were purchased from Fisher Scientific or Sigma 
Aldrich. Anhydrous solvents was purchased from Fisher Scientific and dried by passing 
through an alumina column of a solvent purification system. Silica gel (230-400 mesh) 
used for column chromatography was purchased from Silicycle. Thin layer 
chromatography plates (250 µm thickness) were purchased from Sorbent Technologies or 
Merck. Revered-phase column chromatography was done using a RediSep Rf Gold C18 
column on a Teledyne Isco CombiFlash Rf system. High-performance liquid 
chromatography (HPLC) was performed on a Jasco HPLC system using a Phenomenex 
column (Luna 5u C18(2) 100A; 250 x 4.60 mm, 5 micron). UV absorption spectra were 
obtained on a Jasco V-650 spectrophotometer using a 1 cm path length quartz cuvette. 
Fluorescence emission spectra were taken on a Horiba Jobin-Yvon FluoroLog using a 1 
cm path length fluorescence quartz cuvette. 1H NMR and 13C NMR were recorded on 
either a Bruker DMX 500 (500 MHz) or a Bruker AVII 500 (500 MHz). High-resolution 
mass spectrometry was performed by Dr. Rakesh Kohli at the University of Pennsylvania 
using a Waters LCT Premier XE Mass Spectrometer (model KE 332). X-Ray 
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chromatography was performed by Dr. Pattrick Carroll at the University of Pennsylvania 
using a Bruker APEX2-DUO CCD X-Ray Diffractometer. Photoreactions were carried 
out in a Rayonet Photochemical Reactor (model RPR-100). Quantum yield was 
determined by serial dilution method using fluorescein (in NaOH 0.1 M, Φ = 0.95) as 
reference.22 
 
Synthesis: 
 
The photolysis of (E)-1/(Z)-116 was done using a modified version of a procedure 
reported by Katz et al.25 An oven-dried 25 mL vial was charged with a solution of (E)-
1/(Z)-1 (96 mg, 0.265 mmol) in THF (20 mL). Methyloxirane (1 mL, 14.1 mmol, 53 
equiv) was added.  A very small amount of iodine (sub-stoichiometric) was added to the 
solution before capping and irradiating the vial with 365 nm light in a Rayonet 
photoreactor for 26 h.  The solvent was removed under vacuum. Reverse-phase column 
chromatography using acetonitrile and 0.1% TFA water as eluents was used to separate a 
mixture of protonated 2 and 3 from protonated (E)-1/(Z)-1. The protonated 2/3 mixture 
was transferred to a separatory funnel, treated with saturated sodium bicarbonate, and 
extracted with chloroform (3 x 25 mL).  The 2/3 mixture was then separated on normal-
phase silica gel using 1:1 DCM:EtOAc to provide pure 2 (23 mg; 0.064 mmol, 24%) and 
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3 (48 mg; 0.133 mmol, 50%), both as yellow solids.  Basification and chloroform 
extraction of the protonated (E)-1/(Z)-1 solution provided 9.7 mg of pure recovered (E)-
1/(Z)-1 (10 mg, 0.027 mmol, 10%).  
For 2: 1H NMR (500 MHz, D2O): δ (ppm) 8.65 (s, 2H), 8.21 (d, 2H, J = 4.5 Hz), 
8.13 (d, 2H, J = 8.0 Hz), 7.73 (d, 2H, J = 5 Hz), 7.62 (t, 2H, J = 8 Hz), 7.31 (d, 2H, 8 Hz). 
13C NMR (126.9 MHz, D2O): δ (ppm) 150.4, 149.0, 143.6, 141.3, 130.4, 128.8, 127.6, 
121.4, 119.8, 117.7, 117.5, 113.0. HRMS (m/z): [M+H]+ calcd for C24H13N2O2+, 
361.0972; found, 361.0975. Extinction coefficient ε = 4986 M-1.cm-1 (solvent: 
chloroform). Quantum yield Φ = 0.734 (solvent: chloroform, standard: fluorescein in 
NaOH 0.1 M). 
For 3: 1H NMR (500 MHz, D2O): δ (ppm) 9.41 (s, 1H), 8.62 (s, 1H), 8.55 (s, 1H), 
8.21-8.19 (m, 2H), 7.89 (dd, 1H, J = 8.5, 1.5 Hz), 7.81 (d, 1H, J = 5.5 Hz), 7.63 (t, 1H, J 
= 8.0 Hz), 7.39 (td, 1H, J = 7.5, 1.5 Hz), 7.31 (dd, 1H, J = 8.5, 1.0 Hz), 7.28 (dd, 1H, J = 
8.5, 1.0 Hz), 7.02 (td, 1H, J = 7.5, 1.5 Hz). 13C NMR (126.9 MHz, D2O): δ (ppm) 152.9, 
150.5, 149.2, 146.4, 143.6, 141.3, 140.0, 132.8, 131.5, 129.0, 128.3, 127.9, 127.2, 125.8, 
124.1, 123.4, 122.2, 120.1, 119.7, 119.0, 118.5, 118.4, 117.0, 113.7. HRMS (m/z): 
[M+H]+ calcd for C24H13N2O2+, 361.0972; found, 361.0985. Extinction coefficient ε = 
18085 M-1.cm-1 (solvent: chloroform). Quantum yield Φ = 0.796 (solvent: chloroform, 
standard: fluorescein in NaOH 0.1 M). 
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In a round bottom flask, 2 (6.6 mg, 0.018 mmol) was dissolved in toluene (7 mL). 
Dimethyl sulfate 1% v/v in toluene (0.55 mL, 0.058 mmol) was added and the reaction 
mixture was refluxed under argon. After 18 hours, the reaction mixture was allowed to 
cool down to room temperature. The reaction mixture was filtered. The red residue was 
washed with toluene and diethylether before being redissolved in methanol and dry-
loaded to a reversed phase automated column using 0.1% TFA water and acetonitrile as 
eluents to obtain 417 (2.8 mg, 0.0057 mmol, 31%), and 5 (4.1 mg, 0.0067 mmol, 36%), 
both as orange-red solids. The starting material 2 was also recovered after the column 
(1.4 mg, 0.0038 mmol, 21%). 
For 4: 1H NMR (500 MHz, CDCl3): δ (ppm) 8.57 (1.0, s), 8.27 (1.0, s), 8.10 (1.0, 
d, J = 6.5 Hz), 7.93 (1.0, d, J = 5.5 Hz), 7.68 (1.0, d, J = 6.5 Hz), 7.51 (1.0, d, J = 8.0 Hz), 
7.45 (1.0, d, J = 8.0 Hz), 7.38 (1.0, t, J = 8.0 Hz), 7.33 (1.0, t, J = 8.0 Hz), 7.25 (1.0, d, J = 
5.5 Hz), 7.01 (1.0, d, J = 8.0 Hz), 6.87 (1.0, d, J = 8.0 Hz), 4.29 (3.0, s).  13C NMR (126.9 
MHz, CDCl3): δ (ppm) 162.9, 162.6, 150.2, 148.7, 147.5, 147.2, 138.8, 135.8, 130.5, 
130.0, 128.3, 122.8, 120.7, 118.2, 117.9, 117.7, 117.5, 115.2, 114.3, 113.6, 113.4, 47.8. 
HRMS (m/z): [M]+ calcd for C25H15N2O2+, 375.1134; found, 375.1139. Extinction 
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coefficient ε = 10437 M-1cm-1 (solvent: water). Quantum yield Φ = 0.101 (solvent: water, 
standard: fluorescein in 0.1N NaOH). 
For 5: : 1H NMR (500 MHz, D2O): δ (ppm) 8.89 (d, 2H, J = 1.5 Hz), 8.33 (dd, 
2H, J = 6.5, 1.5 Hz), 8.23 (d, 2H, J = 6.5 Hz), 7.87 (d, 2H, J = 8.0 Hz), 7.55 (t, 2H, J = 8.0 
Hz), 7.27 (d, 2H, J = 8.0 Hz), 4.40 (s, 6H). 13C NMR (126.9 MHz, D2O): δ (ppm) 151.6, 
148.8, 139.3, 136.7, 134.9, 130.9, 129.9, 123.7, 119.5, 118.7, 118.3, 114.0. HRMS (m/z): 
[M/2]+ calcd for C13H9NO+, 195.0679; found, 195.0687. Extinction coefficient ε = 9240 
M-1.cm-1 (solvent: water). Quantum yield Φ = 0.133 (solvent: water, standard: fluorescein 
in 0.1N NaOH). 
 
In a round-bottom flask, compound 3 (8.2 mg, 0.023 mmol) was dissolved in 
toluene (8 mL) and a 1% (v/v) solution of dimethyl sulfate in toluene (0.6 mL, 0.068 
mmol) was added. The reaction mixture was heat under reflux under argon for 20 hours 
before allowed to cool down to room temperature. Solvent was removed and the residue 
was washed with 15 mL diethyl ether and dried under vacuum. The residue was dissolved 
in methanol and dry-loaded in celite to a C18 column for a reverse phase chromatography 
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using acetonitrile and 0.1% TFA water as eluents. A mixture of 6/7 (3.2 mg, 0.006 mmol, 
26%) and pure 8 (10.4 mg, 0.016 mmol, 70%) were obtained as orange-red solid. 
For 6/7: 1H NMR (500 MHz, D2O): δ (ppm)	  : 1H NMR (500 MHz, D2O): δ (ppm) 
9.53 (s, 1H Major), 9.34 (s, 1H Minor), 8.81 (s, 1H Minor), 8.72 (s, 1H Major), 8.67 (s, 
1H Major), 8.54 (s, 1H Minor), 8.33 (d, 1H Major, J = 6.3 Hz), 8.26 (d, 1H Minor, J = 6.6 
Hz), 8.24-8.20 (m, 1H Major and 1H Minor), 8.18 (d, 1H Major, J = 8.2 Hz), 8.14 (d, 1H 
Minor, J = 8.3 Hz), 7.85-7.77 (m, 1H Major and 1H Minor), 7.69-7.64 (m, 1H Major and 
1H Minor), 7.58 (d, 1H Major, J = 7.9 Hz), 7.55 (d, 1H Minor, J = 8.1 Hz), 7.53-7.48 (m, 
2H Major and 1H Minor), 7.45 (d, 1H Minor, J = 8.3 Hz), 7.19-7.13 (m, 1H Major and 
1H Minor), 4.57 (s, 3H Major), 4.36 (s, 3H Minor). 13C NMR (126.9 MHz, D2O): δ 
(ppm) 163.3, 162.9, 162.7, 162.4, 159.2, 157.0, 151.4, 151.2, 151.2, 149.3, 148.7, 139.1, 
136.6, 136.0, 135.5, 134.2, 134.1, 133.2, 133.2, 130.9, 130.8, 128.5, 127.9, 127.9, 126.9, 
126.9, 126.4, 125.7, 125.3, 123.8, 123.5, 123.4, 121.8, 121.5, 121.0, 119.8, 119.6, 119.0, 
119.0, 118.6, 118.6, 117.4, 117.2, 116.0, 115.9, 115.1, 112.8, 56.8, 48.8. HRMS (m/z): 
[M]+ calcd for C25H15N2O2+, 375.1128; found, 375.1127. Extinction coefficient ε = 6385 
M-1.cm-1 (solvent: water). Quantum yield Φ = 0.217 (solvent: water, standard: fluorescein 
in 0.1N NaOH). 
For 8: 1H NMR (500 MHz, D2O): δ (ppm) 9.64 (s, 1H), 8.78 (s, 1H), 8.68 (s, 1H), 
8.29 (dd, 1H, J = 6.7, 2.1 Hz), 8.21 (d, 1H, J = 6.7 Hz), 8.12 (d, 1H, J = 8.1 Hz), 7.79 (td, 
1H, J = 7.9, 2.1 Hz), 7.70 (t, 1H, J = 7.9 Hz), 7.56-7.50 (m, 2H), 7.46 (dd, 1H, J = 8.0, 2.1 
Hz), 7.17 (t, 1H, J = 7.7 Hz), 4.55 (s, 3H), 4.32 (s, 3H). 13C NMR (126.9 MHz, D2O): δ 
(ppm) 163.0, 162.7, 151.6, 151.2, 149.2, 148.6, 139.2, 136.6, 136.3, 134.9, 134.4, 130.9, 
127.6, 127.1, 126.4, 125.6, 125.4, 123.9, 121.7, 121.2, 119.2, 119.1, 118.7, 117.1, 116.1, 
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115.2, 48.9, 48.1. HRMS (m/z): [M/2]+ calcd for C16H9NO+, 195.0679; found, 195.0683. 
Extinction coefficient ε = 13326 M-1.cm-1 (solvent: water). Quantum yield Φ = 0.343 
(solvent: water, standard: fluorescein in 0.1N NaOH). 
 
Cell imaging: 
For live cell imaging, HeLa cells and neuro-2a cells (purchased from ATCC) 
were used. Cells were cultured in a 60 mm culture dish or a 75 cm2 culture flask using 
Life Technologies Dulbecco's Modified Eagle Medium (DMEM) media with phenol red, 
10% Fetal Bovine Serum and 1% penicillin-streptomycin at 37 °C in a humidified 
atmosphere with 5% CO2. The cells were detached with 0.05% trypsin-EDTA and 
transferred to a 35 mm glass bottom poly-D-lysine coated dish 2 days before imaging 
with about 2 mL of the above-mentioned media. One microliter of a 5 mM solution of 2, 
3, 4, 5, 6/7, or 8 in MiliQ water or a 10mg/mL solution of Hoechst 3334224 in water were 
mixed with 2 mL new media and added to the cells after the old media was removed. 
After incubation (1 hour to overnight for 2, 3; 3 hours to overnight for 4, 5, 6/7, and 8; 
and 30 minutes for Hoechst 33342), the excess dyes were washed twice with non-phenol 
red DMEM before imaging (optional for 2 and 3). The cells were kept in 1 mL non-
phenol red DMEM during imaging.  
A Leica DM4000 spinning disk confocal microscope equipped with a 100x/1.4 
NA oil immersion objective was used in Figure 4.4. A Leica TCS SP8 confocal 
microscope equipped with a 63x/1.4 NA oil immersion objective lens was used in Figure 
4.6. All image processing was done using Fiji. 
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Preparing paraformaldehyde 4% for fixation: 
In a 250 mL beaker containing 80 mL PBS buffer at 60 °C was added 4 g 
paraformaldehyde. Sodium hydroxide 1M was slowly added until the solution in was 
clear. The solution was allowed to cool down to room temperature, filtered, and 
neutralized by HCl 1M to pH ~ 6.9. PBS buffer was added to a total volume of 100 mL. 
 
Paraformaldehyde fixation: 
After achieving the desired cell confluency (70-90%), media was removed and the 
cells were washed once with prewarmed PBS buffer and once with a prewarmed 4% 
paraformaldehyde solution. The cells was kept in 4% paraformaldehyde at room 
temperature for 20 minutes before the formaldehyde solution was removed and the dish 
was washed twice with PBS buffer. The sample can be kept in PBS buffer at 2-8 °C until 
needed. 
Ethanol fixation: 
After achieving the desired cell confluency, media was removed and the cells 
were washed with PBS buffer, cold ethanol (- 20 °C), then kept in ethanol at – 20 °C. 
After 10 minutes, ethanol was removed and the dish was washed twice with PBS buffer 
and stored in PBS buffer at 2-8 °C until needed. 
  
Cytotoxicity studies: 
In a 96-well plate, HeLa cells were plated at 5,000 cells/well in culture media 
mentioned above (50 µL/well) and incubated at 37 °C in a humidified atmosphere with 
5% CO2. After 24 hours, cells were treated with 2, 3, 4, 5, 6/7, 8 (final concentration 5 
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µM), and MitoTracker Red FM24 (final concentration 1 µM), and DMSO (vehicle control 
for MitoTracker). For wells treated with MitoTracker and DMSO, DMSO concentration 
was kept at 1%. Untreated cells were used as vehicle control for 2, 3, 4, 5, 6/7, and 8. 
Final volumes were 100 µL/well. Cells were incubated at 37 °C in 5% CO2 for 24 or 48 
hours. Alamar Blue (10 µL) was added 2 hours prior to fluorescence measurement. 
Fluorescence was measured at 560 nm excitation and 590 nm emission. Vehicle control 
was taken as 100% cell viability. 
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4.7 Spectra and supplemental information 
Table 4.1.  Summary of Structure Determination of 3. 
Empirical formula  C25H13N2O2Cl3 
Formula weight  479.72 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  C2/c       
Cell constants:   
a  26.245(5) Å 
b  10.808(2) Å 
c  28.103(5) Å 
b 91.015(10)° 
Volume 7970(3) Å3 
Z 16 
Density (calculated) 1.599 Mg/m3 
Absorption coefficient 0.489 mm-1 
F(000) 3904 
Crystal size 0.45 x 0.22 x 0.01 mm3 
Theta range for data collection 1.45 to 25.48° 
Index ranges -29 ≤ h ≤ 31, -12 ≤ k ≤ 13, -33 ≤ l ≤ 33 
Reflections collected 73138 
Independent reflections 7329 [R(int) = 0.0464] 
Completeness to theta = 25.48° 99.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6513 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7329 / 0 / 578 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0456, wR2 = 0.1040 
R indices (all data) R1 = 0.0636, wR2 = 0.1130 
Largest diff. peak and hole 0.522 and -0.466 e.Å-3 
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Figure 4.12. Confocal microscopy images of live HeLa cells incubated with 2 without washing 
excess dyes. The fluorescence images was observed using the 405/465 channel. Scale bar = 10 
µm. 
 
	  131	  
	  
 
Figure 4.13. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
2. The fluorescence images was observed using the 405/465 channel. Scale bar = 10 µm. 
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Figure 4.14. Confocal microscopy images of live neuro-2a cells incubated with 2. The 
fluorescence images was observed using the 405/465 channel. Scale bar = 10 µm. 
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Figure 4.15. Confocal microscopy images of live HeLa cells incubated with 3 without washing 
excess dyes. The fluorescence images was observed using the 405/465 channel. Scale bar = 10 
µm. 
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Figure 4.16. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
3. The fluorescence images was observed using the 405/465 channel. Scale bar = 10 µm. 
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Figure 4.17. Confocal microscopy images of live neuro-2a cells incubated with 3. The 
fluorescence images was observed using the 405/465 channel. Scale bar = 10 µm. 
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Figure 4.18. Timelapse experiment of HeLa cells incubated with 2. Continuous irradiation was 
perform using the 444/495 channel for 30 seconds. Scale bar = 10 µm. 
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Figure 4.19. Timelapse experiment of HeLa cells incubated with 3. Continuous irradiation was 
perform using the 444/495 channel for 30 seconds. Scale bar = 10 µm. 
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Figure 4.20. Timelapse experiment of HeLa cells incubated with MitoTracker Red FM. 
Continuous irradiation was perform using the 594/632 channel for 30 seconds. Scale bar = 10 µm. 
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Figure 4.21. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
4. The fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
 
Figure 4.22. Confocal microscopy images of EtOH-fixed HeLa cells incubated with 4. The 
fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
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Figure 4.23. Confocal microscopy images of live neuro-2a cells incubated with 4. The 
fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure 4.24. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
5. The fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure 4.25. Confocal microscopy images of EtOH-fixed HeLa cells incubated with 5. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure 4.26. Confocal microscopy images of live neuro-2a cells incubated with 5. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
 
 
Figure 4.27. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
6/7. The fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
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Figure 4.28. Confocal microscopy images of EtOH-fixed HeLa cells incubated with 6/7. The 
fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure 4.29. Confocal microscopy images of live neuro-2a cells incubated with 6/7. The 
fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
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Figure 4.30. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
8. The fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
 
 
Figure 4.31. Confocal microscopy images of EtOH-fixed HeLa cells incubated with 8. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure 4.32. Confocal microscopy images of live neuro-2a cells incubated with 8. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure 4.33. Timelapse experiment of HeLa cells incubated with 4. Continuous irradiation was 
perform using the 488/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure 4.34. Timelapse experiment of HeLa cells incubated with 5. Continuous irradiation was 
perform using the 552/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure 4.35. Timelapse experiment of HeLa cells incubated with 6/7. Continuous irradiation was 
perform using the 488/600 channel for 200 seconds. Scale bar = 10 µm. 
 
	  149	  
	  
 
Figure 4.36. Timelapse experiment of HeLa cells incubated with 8. Continuous irradiation was 
perform using the 552/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure 4.37. HPLC chromatogram of 5.   
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Figure 4.37. HPLC chromatogram of 6/7.   
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Figure 4.37. HPLC chromatogram of 8.   
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Figure 4.38. 1H and 13C NMR of 2.    
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Figure 4.39. 1H and 13C NMR of 3 in CDCl3.    
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Figure 4.40. 1H and 13C NMR of 5 in D2O.    
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Figure 4.41. 1H NMR of 6/7 in D2O.    
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 Figure 4.42. 1H NMR of 8 in D2O.    
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Chapter 5 : Photoelectrocyclization as an activation mechanism for organelle-
specific live cell imaging probes 
 
 
 
 
 
 
 
 
 
 
 
The content of this chapter was originally published in Angewandte Chemie International 
Edition. It is adapted with permission from the publisher. 
Tran, M. N.; Chenoweth, D. M. Angew. Chem. Int. Ed., 2015, 54, 6442-6446. 
Copyright 2015 Wiley-VCH Verlag CmbH & Co. KGaA, Weinheim. 
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5.1 Introduction 
Photoactivatable fluorescent probes are powerful tools for studying biological 
systems owing to the high spatial and temporal control afforded by light. 
Photoactivatable probes can be genetically encoded proteins1-6 or small molecules.7,8 
Each of these technologies comes with its own benefits and limitations and may be 
thought of as complimentary to one another depending on the application. The protein 
kaede represents the first discovery of a photoactivatable fluorescent protein, and much 
progress has been made in recent years with similar genetically encoded approaches.9-12 
Small molecule photoactivatable probes have also found widespread use, and they 
generally rely on a small number of photoactivation mechanisms, such as 
photoisomerization,13,14 photouncaging,15-17 photodecomposition of azides,18 or 
photoclick reactions.19-21 These strategies primarily depend on the conversion from an 
initial non-fluorescent state into a fluorescent state. 
Herein, we present a new intracellular imaging probe that utilizes a 
photoactivation mechanism based on a photochemically allowed 6π-
electrocyclization/oxidation reaction. This mechanism expands the toolbox for 
intracellular photoactivatable probes, providing an emissive pre- and post-activated form 
that can be tracked by fluorescence microscopy. To demonstrate this strategy, we 
introduce a water-soluble, noncytotoxic, and readily cell-permeable photoactivatable 
fluorescent probe for mitochondrial-specific live-cell imaging. We compare the 
cytotoxicity of this probe to a commonly used and commercially available mitochondrial 
dye.22 We also demonstrate its utility in spatiotemporally defined live-cell imaging of 
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mitochondria in dense cellular populations through sequential single-cell activation 
experiments. 
5.2 Results and Discussion 
First, we developed a rapid and efficient synthesis of the desired photoactivatable 
probe starting with commercially available 2-cyanopyridine. Following a similar route to 
that reported in our previous studies,23 we elaborated 2-cyanopyridine to thioketone 1. 
Homocoupling of 1 using copper powder in toluene at reflux yielded 1,1’-
diazaxanthilidene 2 as an interconverting mixture of the E and Z isomers in 84% yield 
(Scheme 5.1). Methylation of 2 with dimethyl sulfate afforded the desired 
monomethylated product (E)-3/(Z)-3 in 96% yield. The overall yield of the probe from 
the commercially available starting materials after six steps was 24% (Scheme 5.1). 
Single crystals of (E)-2 and (Z)-3 were obtained by slow evaporation from chloroform/ 
methanol (1:1) and water solutions, respectively. Both structures adopted an anti-folded 
conformation, despite the increased steric hindrance from methylation in (Z)-3 (Scheme 
5.1). Variable-temperature 1H NMR spectroscopy24 of (E)-2/(Z)-2 in deuterated N,N-
dimethylformamide confirmed the dynamic interconversion of the E and Z isomers at 
room temperature, which is consistent with our previous studies.23 At low temperature, 
separate sets of sharp and well-resolved signals were observed for the E and Z isomers of 
3. Incremental heating resulted in significant signal broadening followed by sharpening 
and resolved coupling at high temperature. This result indicates rapid exchange on the 
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NMR timescale. Coalescence was observed at 45 °C, and the activation energy was 
determined to be ΔG‡ = 15.7 kcal.mol-1. 
 
 
Scheme 5.1. Synthesis of (E)-3/(Z)-3 and crystal structures of (E)-2 and (Z)-3. 
 
Upon irradiation at 365 nm using a Rayonet photoreactor, the (E)-3/(Z)-3 mixture 
was found to undergo photocyclization followed by oxidation to yield photoproduct 4 
(Figure 5.1a). To promote the photocyclization step of (E)-3/(Z)-3, both the anti-folded 
conformation and dynamic interconversion are crucial. According to the Woodward–
Hoffmann rules, electrocyclization of the 1,3,5-hexatriene moiety of (Z)-3 (4n+2 electron 
system) is thermally allowed in a disrotatory manner and photochemically allowed in a 
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conrotatory manner.25,26 The anti-folded conformation of (Z)-3 is preorganized for 
conrotatory cyclization, satisfying the requirement for the photochemical reaction. This 
conclusion was further confirmed by TD-DFT calculations27 on (Z)-3. As is evident from 
the calculated molecular orbitals, a conrotatory cyclization leads to constructive 
interactions and is photochemically favored (Figure 5.1b). The structure of (E)-3 is 
disfavored for electrocyclization but E-Z isomerization leads to the formation of (Z)-3, 
facilitating the photoreaction. As a result, the dihydrophenanthrene intermediate was 
attained, which was followed by oxidation to give photoproduct 4. The 
dihydrophenanthrene intermediate was not isolable from the reaction mixture. 
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Figure 5.1. Photoreaction of (E)-3/(Z)-3. A) E-Z interconversion and photocyclization/oxidation 
reaction of (E)-3/(Z)-3. B) Idealized and calculated LUMO of (Z)-3 (TD-DFT B3LYP, 6-
311+G(2d,p) basis set). Note the orbital preorganization for photochemically favored conrotatory 
cyclization. C) Absorbance and emission spectra of (E)-3/(Z)-3 [λmax = 408 nm (abs.), 543 nm 
(em.), ε = 11,040 M-1.cm-1, Φ = 0.021, τ = 0.97 ns] and 4 [λmax = 504 nm (abs.), 612 nm (em.), ε = 
11,496 M-1.cm-1, Φ = 0.100, τ = 4.77 ns] in water. 
 
Compound (E)-3/(Z)-3 is fluorescent with a large Stokes shift (135 nm). 
Photoproduct 4 is red-shifted in both absorbance and emission by approximately 100 nm 
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while a large Stokes shift of 108 nm is retained (Figure 5.1c). Live-cell imaging studies 
of (E)-3/(Z)-3 were performed with HeLa cells, and specific sub-cellular localization was 
observed, consistent with mitochondrial uptake. An engineered HeLa cell line that 
expresses GFP-labeled proteins specifically localized to the outer mitochondrial 
membrane (mito-GFP cell line), as introduced in one of our previous studies,16 was used 
as a control to confirm the mitochondrial localization of (E)-3/(Z)-3 in this report. The 
localization statistics were also compared to those of a commonly used and commercially 
available MitoTracker dye.22 Our control cell line consisted of a population of HeLa cells 
expressing a GFP fusion protein localized specifically to the outer mitochondrial 
membrane (mito-GFP cell line) in addition to a population of non-GFP-expressing HeLa 
cells, which served as an internal control for compound localization in the absence of the 
GFP signal. Two channels, 405/635 and 488/525 were used to detect (E)-3/(Z)-3 and 
GFP, respectively, with no bleed-through observed. All images were recorded at the same 
brightness and contrast settings. Incubating mito-GFP cells with (E)-3/(Z)-3 allowed for 
colocalization to be assessed (Figure 5.2a). Colocalization statistics calculated over 
multiple frames for a total of 80 cells showed significant overlap (Pearson's coefficient: 
0.81 ± 0.02; Manders' coefficients: 0.98 ± 0.01 and 1.00 ± 0.00; Spearman correlation: 
0.88 ± 0.02). High Manders' coefficients point to near exclusive mitochondrial 
localization of (E)-3/(Z)-3 in GFP-positive cells. Variations in intensity between 
localized (E)-3/(Z)-3 and GFP resulted in a slightly lower Pearson's coefficient. This 
small deviation may be attributed to the difference between internal mitochondrial 
localization of (E)-3/(Z)-3 versus external mitochondrial membrane localization of GFP. 
Intensity profiles across multiple cells are shown in Figure 5.2a. Additional 
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colocalization studies were carried out using commercially available Mitotracker Red,22 
and similar results were observed when comparing the colocalization with GFP labeled 
mitochondria. High signal-to-noise ratios were observed in the intensity line plots for 
both GFP and (E)-3/(Z)-3 (Figure 5.2a). The stability of a 1 mM aqueous solution of (E)-
3/(Z)-3 was assessed under ambient light conditions at 25 °C for ten days. HPLC analysis 
of the resulting solution revealed no evidence for decomposition or photoconversion 
compared to a standard sample of photoproduct 4 (Figure 5.2b). Cytotoxicity studies on 
HeLa cells over 24, 48, and 72 hours confirmed that (E)-3/(Z)-3 had very low 
cytotoxicity. For comparison, MitoTracker Red FM, one of the most commonly used 
mitochondrial imaging probes, showed significant cytotoxicity over the same time course 
at a five-fold lower concentration (Figure 5.2c). 
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Figure 5.2a. Colocalization of (E)-3/(Z)-3 and GFP. Confocal images of mito-GFP cells (right), 
HeLa cells stained with (E)-3/(Z)-3 (middle), and mito-GFP cells stained with (E)-3/(Z)-3 (left). 
Compound (E)-3/(Z)-3 was observed at 405/635 nm while GFP was observed at 488/525 nm. All 
images were kept at the same contrast/brightness, and bleed-through between channels was not 
detected. Scale bar = 10 µm. Line plot of the fluorescence intensity across multiple cells showing 
high colocalization and signal-to-noise ratios for both GFP and (E)-3/(Z)-3. In the colocalization 
plot in the bottom left of panel A, the nuclear regions in adjacent cells are designated with “n”. 
Pearson’s colocalization coefficient: 0.87 ± 0.01; Manders’ overlap coefficients: 0.98 ± 0.01 and 
1.00 ± 0.00. 
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Figure 5.2b. HPLC chromatogram of (E)-3/(Z)-3 (1 mm solution in water) after ten days under 
ambient light (top chromatogram) and HPLC chromatogram of 4 (bottom chromatogram). No 
decomposition products or the photoproduct of (E)-3/(Z)-3 were detected. 
 
 
Figure 5.2c. Cell viability assay of (E)-3/(Z)-3 and MitoTracker Red FM. The assay was 
performed using HeLa cells in the presence of 5 µm (E)-3/(Z)-3 or 1 µm MitoTracker Red FM. 
 
By combining the observed photoreaction (Figure 5.1a) with the ability to 
selectively label mitochondria for live-cell imaging (Figure 5.2a), intracellular 
photoactivation of (E)-3/(Z)-3 was attempted. As the absorbance and emission spectra of 
4 are red-shifted by approximately 100 nm compared to those of (E)-3/(Z)-3, the 
individual species can be selectively excited. Alternating use of the two channels (i.e., 
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444/525 for (E)-3/(Z)-3 and 488/632 for 4) resulted in the photoconversion of (E)-3/(Z)-3 
into 4 in live cells. A significant increase in the fluorescence intensity of 4 was achieved 
after 30 seconds, using 200 total scans (Figure 5.3a,b). To further investigate the spatial 
selectivity, a targeted 405 nm laser (CrystaLaser, DL405-050-O) was used to target 
smaller areas of the cells. Confocal images were captured using a 488 nm excitation laser 
and a 632 nm emission filter. Immediately after the first activation, a bright signal was 
detected at the targeted region. The tubular morphology of the mitochondria was 
observed, and the remaining portions of the mitochondria remained dim for an additional 
ten seconds using the 488 nm excitation laser (Figure 5.3c). 
 
 
Figure 5.3a. Confocal microscopy images for timelapse experiment of (E)-3/(Z)-3. The images 
were observed at 444/525 nm and 488/632 nm over 30 s with 200 alternating 150 ms pulses. 
Scale bar: 10 µm. 
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Figure 5.3b. Timelapse experiment of (E)-3/(Z)-3. Average intensity of the 444/525 and 488/632 
channels after 200 alternating pulses were normalized to the starting value of channel 444/525. 
The data from each of the two channels were fitted to a one-phase exponential curve, and the 
obtained rate constants and half-lives were 0.060 s-1 and 11.61 s for the 444/525 channel and 
0.030 s-1 and 23.05 s for the 488/632 channel.  
 
 
Figure 5.3c. Sequential activation experiment of (E)-3/(Z)-3. A 405 nm spot laser was used as 
activating laser while a 488/632 channel was used to observed the photoproduct signal. 
Normalized intensity plot for the sequential photoactivation of two cells was included. Dashed 
lines indicate cell boundaries. Scale bar: 10 µm. 
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Figure 5.3d. Sequential activation experiment of (E)-3/(Z)-3 in a crowded environment. 
Selective sequential photoactivation of two cells (7 and 19) individually among a field of view 
containing 20 confluent cells was performed. Each cell was activated by fifty 20 s pulses of a 
normal 405 nm FRAP laser. Dashed lines indicate cell boundaries. Scale bar: 10 µm. 
 
Finally, we wanted to show that individual cells can be photoactivated in 
extremely crowded confluent cellular environments. A normalized intensity plot for the 
sequential photoactivation of two adjacent cells is shown in Figure 5.3c. A standard 405 
nm laser commonly used for photobleaching experiments was used for sequential 
photoactivation with excellent spatial control over individual cells in crowded 
environments (Figure 5.3d). Using 50 pulses with a length of 20 s, the mitochondrial 
probe (E)-3/(Z)-3 was photoconverted into 4. Two individual cells out of 20 cells were 
sequentially photoactivated (cell 7 and cell 19, Figure 5.3d). 
5.3 Conclusions 
In conclusion, we have developed a photoactivatable probe that is based on a 6π 
electrocyclization/oxidation mechanism. The probe is water-soluble, cell-permeable, non-
cytotoxic, and can selectively stain mitochondria. This photoactivation strategy should be 
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broadly applicable to many dye classes, and further studies are underway to develop new 
cellular imaging tools. 
5.4 Material and Methods 
General information: 
n-Butyllithium in hexanes was purchased from Acros and titrated with 
diphenylacetic acid, which was recrystallized from toluene. All other reagents were 
purchased from Sigma Aldrich and used without further purification. Solvents were 
purchased from either Sigma Aldrich or Fisher Scientific. Anhydrous solvents was 
purchased from Fisher Scientific and dried by passing through an alumina column of a 
solvent purification system. Silica gel (230-400 mesh) used for column chromatography 
was purchased from Silicycle. Thin layer chromatography plates (250 µm thickness) 
were purchased from Sorbent Technologies. Revered-phase column chromatography was 
done using a RediSep Rf Gold C18 column on a Teledyne Isco CombiFlash Rf system. 
High-performance liquid chromatography (HPLC) was performed on a Jasco HPLC 
system using a Phenomenex column (Luna 5u C18(2) 100A; 250 x 4.60 mm, 5 micron). 
UV absorption spectra were obtained on a Jasco V-650 spectrophotometer using a 1 cm 
path length quartz cuvette. Fluorescence emission spectra were taken on a Horiba Jobin-
Yvon FluoroLog using a 1 cm path length fluorescence quartz cuvette. 1H NMR and 13C 
NMR were recorded on either a Bruker DMX 500 (500 MHz) or a Bruker AVII 500 (500 
MHz). High-resolution mass spectrometry was performed by Dr. Rakesh Kohli at the 
University of Pennsylvania using a Waters LCT Premier XE Mass Spectrometer (model 
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KE 332). X-ray chromatography was performed by Dr. Pattrick Carroll at the University 
of Pennsylvania using a Bruker APEX2-DUO CCD X-ray Diffractometer. Photoreactions 
were carried out in a Rayonet Photochemical Reactor (model RPR-100). Quantum yield 
was determined by serial dilution method using coumarine 153 (in ethanol, Φ = 0.38) and 
fluorescein (in NaOH 0.1 M, Φ = 0.95) as standards.28,29 
 
Synthesis: 
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Scheme 5.2. Synthesis of (E)-3/(Z)-3. 
 
 
 
To a solution of phenol (1124 mg, 11.9 mmol) in anhydrous DMF (20 mL) was 
added sodium hydride (60% dispersion in mineral oil, 490 mg, 12.3 mmol). After 
hydrogen evolution ceased, 3-chloro-2-cyanopyridine30 was added neat and the reaction 
was heated to 80 °C for 3 hours. DMF was removed under reduced pressure and the 
residue was dissolved in a mixture of water and DCM. The aqueous layer was extracted 
with DCM and the combined organic layer was washed with NaOH 2M and brine, dried 
with Na2SO4, filtered and concentrated in vacuo. Out of 2315 mg of the obtained crude 
biaryl ether,31 1933 mg was transfer to a 250 mL beaker to carry out the ring closing 
reaction with 80 g polyphosphoric acid. The reaction mixture was heated in a sand bath to 
260 °C for 2 hours. The reaction mixture was allowed to cool down to room temperature, 
poured over ice and rinsed with distilled water. The solution was neutralized with 
concentrated NaOH to pH 7 and extracted with DCM. The combined organic layers were 
washed with brine, dried with Na2SO4, filtered, and concentrated in vacuo to obtain 1-
azaxanthone31 as a white powder (1498 mg, 7.6 mmol, 84% yield after 2 steps). 1H NMR 
(500 MHz, CDCl3): δ (ppm) 8.77 (2H, dd, J = 4.0 Hz, 1.5 Hz), 8.37 (2H, dd, J = 8.0 Hz, 
1.5 Hz), 7.85 (2H, dd, J= 8.5 Hz, 1.5 Hz), 7.71 (2H, td, J = 7.5 Hz, 1.5 Hz), 7.63 (2H, dd, 
J = 8.5 Hz, 4.0 Hz), 7.46 (2H, d, J = 8.5 Hz), 7.37 (2H, t, J = 7.5 Hz). 13C NMR (126.9 
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MHz, CDCl3): δ (ppm) 176.1, 155.5, 153.7, 147.1, 137.5, 135.4, 128.7, 127.3, 127.0, 
124.5, 123.2, 118.1. HRMS (m/z): [M + H]+ calcd for C12H8NO2, 198.0555; found, 
198.0552. 
 
In a round bottom flask, 1-azaxanthone4 (1089 mg, 5.5 mmol) and Lawesson's 
reagent (1167 mg, 2.9 mmol) were added and dried under high vacuum at 40 °C for 5 
hours. Toluene (15 mL) was added and the reaction mixture was refluxed under argon for 
1 hour. The crude mixture was concentrated under reduced pressure and purified by silica 
gel column chromatography using 5:95 EtOAc:DCM to give a green powder (783 mg, 
3.7 mmol, 67% yield). 1H NMR (500 MHz, CDCl3): δ (ppm) 8.74 (2H, dd, J = 4.5 Hz, 
1.5 Hz), 8.58 (2H, dd, J = 8.5 Hz, 1.5 Hz), 7.80 (2H, dd, J = 8.0 Hz, 1.5 Hz), 7.67 (2H, td, 
J = 8.0 Hz, 1.5 Hz), 7.60 (2H, dd, J = 8.5 Hz, 4.5 Hz), 7.37 (2H, d, J = 8.5 Hz), 7.27 (2H, 
t, J = 8.0 Hz). 13C NMR (126.9 MHz, CDCl3): δ (ppm) 204.2, 150.0, 148.3, 148.1, 142.5, 
135.3, 131.0, 130.0, 128.5, 127.9, 125.5, 118.5. HRMS (m/z): [M + H]+ calcd for 
C12H8NOS, 214.0327; found, 214.0317. 
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In a 2-necked round bottom flask, copper powder (7884mg, 124.0 mmol) and 120 
ml anhydrous toluene was added. Most of the toluene was distilled off to remove any 
trace of water. The distillation apparatus was replaced with a condenser and purge with 
argon for about 15 minutes. In a separate flask, thioketone 1 (783 mg, 3.7 mmol) was 
dried under vacuum for 3 hours, then dissolved in 50 mL toluene and cannulated to the 
copper-toluene mixture. The reaction mixture was heated under reflux for 15 hours. The 
reaction mixture was then filtered, washed with boiling chloroform, and concentrated in 
vacuo. The crude mixture was purified by silica gel column chromatography using 1:9 
EtOAc:DCM to obtain (E)-2/(Z)-2 as a light yellow powder (557 mg, 1.5 mmol, 84% 
yield). 1H NMR (500 MHz, CD2Cl2): δ (ppm) 8.15 (2H, s), 8.07 (2H, s), 7.60-7.55 (4H, 
m), 7.36-7.20 (14H, m), 6.97-6.90 (6H, m). 13C NMR (126.9 MHz, CD2Cl2): δ (ppm) 
154.9, 154.4, 151.2, 150.7, 144.1, 143.8, 129.6, 129.5, 128.8, 128.4, 124.5, 124.3, 123.8, 
123.4, 122.7, 117.7, 117.1. HRMS (m/z): [M + H]+ calcd for C24H15N2O2, 363.1134; 
found, 363.1135. 
 
 
A mixture of (E)-2/(Z)-2 (93 mg, 0.26 mmol) was dissolved in 20 mL chloroform 
and purged with argon for about 15 minutes. The reaction mixture was heated to 60 °C 
for 36 hours. Distilled water (5 mL) was added and the solution was stirred for about 2 
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hours. Chloroform was removed under reduced pressure and the aqueous solution was 
loaded on celite and purified by reversed-phase column chromatography using 0.1%TFA 
in water and acetonitrile as eluents. The obtained yellow powder was a 3:10 mixture of 
(E)-3/(Z)-3  (121 mg, 0.25 mmol, 96% yield).  1H NMR (500 MHz, D2O): δ 8.50 (0.3, d, 
J = 8.5 Hz), 8.44 (0.3, d, J = 6 Hz), 8.38 (1.0, d, J = 6 Hz), 8.32 (1.0, d, J = 8.5 Hz), 8.22 
(0.3, d, J = 4 Hz), 8.09 (1.0, dd, J = 4.5 Hz, 1.0 Hz), 8.04 (0.3, dd, J = 8.5 Hz, 6.5 Hz), 
7.97 (0.3, d, J = 9.0 Hz), 7.93 (1.0, dd, J = 8.5 Hz, 6.0 Hz), 7.86 (1.0, dd, J = 8.5 Hz, 1.0 
Hz), 7.69 (0.3, dd, J = 8.0 Hz, 5.0 Hz), 7.59-7.46 (4.2, m), 7.42 (1.0, td, J = 8.0 Hz, 2.0 
Hz), 7.37-7.33 (2.0, m), 7.26-7.15 (1.6, m), 7.07 (0.3, t, J = 7.0 Hz), 6.95-6.90 (2.0,m), 
6.31 (0.3, d, J = 7.5 Hz), 3.46 (0.9, s), 3.37 (3.0, s). 13C NMR (126.9 MHz, D2O): δ (ppm) 
154.8, 153.7, 153.6, 152.8, 149.5, 145.4, 142.4, 140.7, 138.9, 131.7, 131.1, 130.3, 128.9, 
127.3, 127.0, 126.6, 125.6, 125.2, 123.4, 122.0, 119.5, 117.5, 117.3, 113.2, 44.5; 
CF3COO-: 162.9 (m), 116.3 (m). HRMS (m/z): [M]+ calcd for C25H17N2O2, 377.1290; 
found, 377.1290. Extinction coefficient ε = 11040 M-1.cm-1 (solvent: water). Quantum 
yield Φ = 0.021 (solvent: water, standard: coumarine 153 in ethanol). 
 
  
A solution of (E)-3/(Z)-3 (5.2 mg, 0.011 mmol) in 20 mL HCl 0.1M was injected 
into a teflon tube, which was wrapped around a graduated cylinder, to increase surface 
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area. The teflon tube was held in place by transparent tape and copper wire. The two ends 
was clamped together using a Hoffmann clip. The reaction was taken place in a 
photoreactor using 355 nm lamp. After 4 days, solvent was evaporated under reduced 
pressure. The crude mixture was purified using reversed-phase column chromatography 
using 0.1% TFA in water and acetonitrile, giving a red solid (4.9 mg, 0.010 mmol, 94% 
yield). 1H NMR (500 MHz, D2O): δ 8.29 (1H, d, J = 6.0 Hz), 8.09-8.06 (2H, m), 7.85 
(1H, dd, J = 8.5 Hz, 6.0 Hz), 7.57 (1H, dd, J = 8.0 Hz, 1.5 Hz), 7.51-7.46 (3H, m), 7.36 
(1H, t, J = 8.0 Hz), 7.29 (1H, t, J = 8.0 Hz), 6.98 (2H, t, J = 6.5 Hz), 3.30 (1H, s). 13C 
NMR (126.9 MHz, D2O): δ 153.7, 148.7, 148.7, 147.2, 145.4, 141.9, 140.0, 136.5, 130.6, 
130.3, 129.7, 128.4, 128.3, 128.0, 126.9, 126.5, 125.8, 121.3, 118.5, 118.1, 117.0, 113.2, 
112.6, 105.7, 46.1; CF3COO-: 163.0 (m), 116.3 (m). HRMS (m/z): [M]+ calcd for 
C25H17N2O2, 377.1290; found, 377.1290. Extinction coefficient ε = 11496 M-1.cm-1 
(solvent: water). Quantum yield Φ = 0.100 in (solvent: water, standard: fluorescein in 
NaOH 0.1 M). 
 
Cell imaging: 
For live cell imaging, HeLa cells and HeLa cells expressing a mitochondrial outer 
membrane targeting domain from Listeria monocytogenes (ActA, C-terminal 47 amino 
acids) fused to a HaloTag-GFP construct16 were used. Cells were cultured in a 60 mm 
culture dish using Life Technologies Dulbecco's Modified Eagle Medium (DMEM) 
media with phenol red, 10% Fetal Bovine Serum and 1% penicillin-streptomycin at 37 °C 
in a humidified atmosphere with 5% CO2. The cells were detached with 0.05% trypsin-
EDTA and transferred to a 35 mm glass bottom poly-D-lysine coated dish 2-5 days 
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before imaging with about 2 mL of the above-mentioned media. A 5 mM solution of (E)-
3/(Z)-3 in MiliQ water and a 1 mM solution of MitoTracker Red FM in DMSO were 
prepared. Two microliter of each solution was mixed with 2 mL new media and added to 
the cells after the old media was removed. After incubation (3 hours to overnight for (E)-
3/(Z)-3 and 1 hour for MitoTracker Red FM), the excess dyes were washed twice with 
non-phenol red DMEM before imaging. The cells were kept in 2 mL non-phenol red 
DMEM during imaging.  
A Leica TCS SP8 confocal microscope equipped with a 63x/1.4 NA oil 
immersion objective lens was used in Figure 5.2a, 3c. To selectively observe (E)-3/(Z)-3, 
the excitation wavelength of 405 nm and the emission wavelength range of 620-650 were 
used. To selectively observe MitoTracker Red FM, the excitation wavelength of 638 nm 
and the emission wavelength range of 650-700 were used. To selectively observe GFP, 
the excitation wavelength of 488 nm and the emission wavelength range of 500-550 were 
used. 
A Leica DM4000 spinning disk confocal microscope equipped with a 100x/1.4 
NA oil immersion objective was used in Figure 5.3a. In Figure 5.3a, two channels were 
used. The first channel has 444 nm excitation wavelength and 525 nm emission 
wavelength (emission bandpass filter, bandwidth = 36 nm). The second channel has 488 
nm excitation wavelength and 632 nm emission wavelength (emission bandpass filter, 
bandwidth = 60 nm). The two channels were used alternatingly to carry out 200 150-ms 
pulses. All image processing was done using ImageJ. All curve fitting was done using 
Prism. 
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Cytotoxicity studies: 
In a 96-well plate, HeLa cells were plated at 5,000 cells/well in culture media 
mentioned above (50 µL/well) and incubated at 37 °C in a humidified atmosphere with 
5% CO2. After 24 hours, cells were treated with (E)-3/(Z)-3 (final concentration 5 µM), 
MitoTracker Red FM (final concentration 1 µM), and DMSO (vehicle control for 
MitoTracker). For wells treated with MitoTracker and DMSO, DMSO concentration was 
kept at 1%. Untreated cells were used as vehicle control for (E)-3/(Z)-3. Final volumes 
were 100 µL/well. Cells were incubated at 37 °C in 5% CO2 for 24, 48, or 72 hours. 
Alamar Blue (10 µL) was added 2 hours prior to fluorescence measurement. Fluorescence 
was measured at 560 nm excitation and 590 nm emission. Vehicle control was taken as 
100% cell viability. 
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5.7 Spectra and supplemental information 
 
Table 5.1.  Summary of Structure Determination of (E)-2. 
Empirical formula  C24H14N2O2 
Formula weight  362.37 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/n      
Cell constants:   
a  8.4277(3) Å 
b  11.1171(3) Å 
c  9.2467(3) Å 
b 98.745(2)° 
Volume 856.27(5) Å3 
Z 2 
Density (calculated) 1.405 Mg/m3 
Absorption coefficient 0.091 mm-1 
F(000) 376 
Crystal size 0.48 x 0.25 x 0.20 mm3 
Theta range for data collection 2.89 to 25.38° 
Index ranges -10 ≤ h ≤ 10, -13 ≤ k ≤ 13, -11 ≤ l ≤ 11 
Reflections collected 11274 
Independent reflections 1565 [R(int) = 0.0173] 
Completeness to theta = 25.38° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6843 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1565 / 0 / 128 
Goodness-of-fit on F2 1.138 
Final R indices [I>2sigma(I)] R1 = 0.0345, wR2 = 0.0828 
R indices (all data) R1 = 0.0356, wR2 = 0.0837 
Largest diff. peak and hole 0.165 and -0.182 e.Å-3 
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Table 5.2.  Summary of Structure Determination of (Z)-3. 
Empirical formula  C25H21N2O4Cl1.42 
Formula weight  463.78 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group  P1
_
  
Cell constants:   
a  9.3315(3) Å 
b  10.6475(4) Å 
c  13.0424(4) Å 
a 70.814(2)° 
b 79.388(2)° 
g 64.308(2)° 
Volume 1101.56(6) Å3 
Z 2 
Density (calculated) 1.398 Mg/m3 
Absorption coefficient 0.260 mm-1 
F(000) 482 
Crystal size 0.25 x 0.18 x 0.08 mm3 
Theta range for data collection 1.66 to 25.42° 
Index ranges -11 ≤ h ≤ 11, -12 ≤ k ≤ 12, -15 ≤ l ≤ 15 
Reflections collected 22110 
Independent reflections 4047 [R(int) = 0.0216] 
Completeness to theta = 25.42° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.7044 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4047 / 0 / 302 
Goodness-of-fit on F2 1.041 
Final R indices [I>2sigma(I)] R1 = 0.0458, wR2 = 0.1155 
R indices (all data) R1 = 0.0493, wR2 = 0.1186 
Largest diff. peak and hole 0.797 and -0.536 e.Å-3 
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Fluorescence lifetime measurement: 
All samples were dissolved in water. Fluorescence lifetime measurement was 
performed using Time-Correlated Single Photon Counting (TCSPC). Two picosecond 
diode lasers (PicoQuant GmbH; Berlin, Germany) were used to generate excitation 
wavelength of 405 nm (for (E)-3/(Z)-3) and 482 nm (for 4). Emission wavelengths were 
560 nm (for (E)-3/(Z)-3) and 620 nm (for 4). Becker-Hickl TCSPC boards were used for 
data acquisition. Data analysis was performed with FluoFit software (Picoquant) using a 
single exponential decay model. 
 
 
Figure 5.4. Lifetime intensity plots for (E)-3/(Z)-3 (panel A) and 4 (panel B) in water. Residuals 
are shown beneath each intensity plot. Lifetimes and reduced χ2 values are given in the upper 
right corner.  
 
	  186	  
	  
 
Figure 5.5. Variable temperature 1H NMR of (E)-2/(Z)-2 in DMF-d7. Coalescence was observed 
at 45 °C, and the activation energy was determined to be ΔG‡ = 15.7 kcal/mol. 
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Figure 5.6. Confocal images of mixed HeLa and mito-GFP cells stained with (E)-3/(Z)-3. (A) 
Channel 405/635 to detect (E)-3/(Z)-3. (B) Channel 488/525 to detect GFP. (C) Merged image of 
A and B. (D) Colocalized pixel map, white: colocalized, red: (E)-3/(Z)-3 only, green: GFP only. 
Scale bar = 10 µm. 
  
	  188	  
	  
 
Figure 5.7. Costaining experiments of MitoTracker Red FM and GFP. (A) Confocal images of 
mito-GFP cells (right panel), HeLa cells stained with MitoTracker Red FM (middle panel), and 
mito-GFP cells and non-GFP cells stained with MitoTracker Red FM (left panel). MitoTracker 
Red FM was observed at 638/675 while GFP was observed at 488/525. No bleed-through was 
detected. All images were kept at the same contrast/brightness. Scale bar = 10 µm. (B) Line plot 
of fluorescence intensity across multiple cells. “n” was used to indicate the area of the nucleus. 
Pearson’s colocolzation coefficient was 0.92 ± 0.02. Manders’ overlap coefficients were 0.99 ± 
0.01 and 1.00 ± 0.00.  
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Figure 5.8. HPLC chromatogram of (E)-3/(Z)-3. 
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Figure 5.9. HPLC chromatogram of a 1 M aqueous solution of (E)-3/(Z)-3 after 10 days under 
ambient light. 
 
 
	  191	  
	  
 
 
Figure 5.10. HPLC chromatogram of 4.   
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Figure 5.11. 1H and 13C NMR of 1-azaxanthone.   
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Figure 5.12. 1H and 13C NMR of 1.   
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Figure 5.13. 1H and 13C NMR of (E)-2/(Z)-2.   
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Figure 5.14. 1H and 13C NMR of (E)-3/(Z)-3.   
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 Figure 5.15. 1H and 13C NMR of 4.   
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Chapter 6 : Conclusion and future directions 
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In this dissertation, we have successfully synthesized the reported structure of the 
natural product xylopyridine A and investigated its intriguingly dynamic conformational 
behavior. Its derivatives and isomers have also been made and showed great potential as 
structure-specific nucleic acid binders and fluorescent dyes for live cell imaging. 
Xylopyridine A is a nucleic acid binding natural product isolated from the 
mangrove fungus Xylaria in 2009. Its proposed structure is an (E)-3,3'-diazaxanthilidine 
with an optically active twisted conformation, and was reported to bind to B-form DNA 
in a unique mode of intercalation. We have made the desired molecule after an efficient 
five-step synthesis; surprisingly, distinct differences between the obtained analytical data 
and those of the isolation paper were observed. A combination of theoretical and 
experimental studies have been conducted, the structure of our product was confirmed to 
be, indeed, the reported structure of xylopyridine A, and an achiral conformational 
dynamic anti-folded structure was revealed. This reported structure itself has proved 
fascinating. Its mono-methylated derivative showed remarkable selectivity toward G-
quadruplex nucleic acid structures. The ability to exclude non-selective duplex binding 
could be attributed to the lack of planarity and elevated height of the anti-folded 
conformation, disfavoring base pair intercalation. More investigation into the nucleic acid 
binding ability of other diazaxanthilidene derivatives will be conducted with the focus on 
developing G-quadruplex binders with higher affinity and similar or greater selectivity. 
Both the mono- and di-methylated derivatives of 3,3'-diazaxanthilidene were used 
as lysosomal stains in live cell imaging. The mono-methylated compounds were found to 
be photoconvertible fluorescent dyes, a group of photoactivatable dyes which possess an 
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added advantage of visualizing the pre-activated state, allowing more accurate and 
precise activation. To the best of our knowledge, very few example of small molecule 
photoconvertible fluorescent dyes have been reported; most photoconvertible fluorescent 
probes so far have been fluorescent proteins. Under a 405 nm laser, the mono-methylated 
derivatives could undergo photocyclization/oxidation reaction in cells, leading to a more 
red-shifted photoproduct with increased brightness. Both the pre- and post-activated 
compounds were water soluble and cell permeable with a large Stokes shift and low 
cytotoxicity. Sequential activation experiments have been carried out to confirm the 
capability of precise spatial and temporal control.  
An E-Z mixture of the regio-isomers mono-methylated 1,1'-diazaxanthilidene was 
also synthesized. Similar properties including high water solubility, cell permeability, 
large Stokes shift, low cytotoxicity, and high spatio-temporal control were observed. 
However, this isomer accumulated in mitochondria, instead of lysosomes, and showed 
higher photostability. Owing to greater photostability, a stronger activating laser was 
required, which was obtained by using a 50 mW diode pump 405 nm targeted laser. 
However, its photostability presented a distinct advantage for simpler spatial and 
temporal control with much lower risk of premature activation. It also allowed sample 
preparation and handling under room light without photoconversion or 
photodecomposition.  
Photoproducts of the 3,3'-diazaxanthilidene have been synthesized and showed 
remarkably high quantum yield. They were also cell-permeable, photostable with low 
cytotoxicity and sufficient Stokes shift. The Stokes shift was significantly improved 
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following methylation. The methylated photoproducts were water soluble and retained 
the remarkable resistance to photobleaching of the parent compounds. All but one 
methylated photoproducts accumulated primarily in the nuclei in live cell imaging. 
Nuclear selectivity was tremendously improved in fixed specimens. A complete change 
from cytoplasmic vesicle to nucleus localization was observed in one of the derivatives. 
For the two photoconvertible fluorescent dyes, future collaborations on cell 
marking followed by fluorescence-based cell sorting to isolate the populations of interest 
will be undertaken. The photoactivatable mitochondrial stain can also be used to track 
and monitor a small group of mitochondria to explore their interaction within the cell as 
well as possible communication with neighboring cells. 
	  
Figure 6.1. Chemical structures of four homomerous diazaxanthilidene regio-isomers. 
 
More studies will be carried out on the remaining two diazaxanthilidene isomers, 
2,2'-diazaxanthilidene and 4,4'-diazaxanthilidene, to investigate and fully exploit their 
potential as structure-specific nucleic acid binders and fluorescent dyes for cell imaging. 
Designing diazaxanthilidene-based photoactivatable membrane stains using long 
aliphatic linkers, and photoactivatable probes for protein labeling using HaloTag 
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technology have been attempted. Although the studies have not been successful so far, 
more derivatives focusing on varying the linker structures will be synthesized and tested. 
New sites for derivatization on the benzene ring will be inserted. Heteromerous 
bistricyclic aromatic enes resulted from linking two different tricyclic moieties together 
will be synthesized and their applicability in cell imaging and nucleic acid binding will be 
assessed.  
 
 
	  
 
 
